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 Quiescence, a transitory period of non-growth, is a ubiquitous aspect that is present in all 
organisms. In addition to being present in all forms of life, quiescence is a feature that has been 
observed in cells that are important for human health, including stem cells in mammals and 
antibiotic tolerant cells in bacteria. In bacteria, quiescence per se has recently been suggested to 
underlie the transient tolerance to a wide range of antibiotics. Furthermore, most microbial life 
exists in a quiescent state. Despite their prevalence and importance, relatively little is known about 
the physiology of quiescent bacteria. One aspect of bacterial quiescence that has been repeatedly 
observed is their lowered metabolic activity compared to actively growing bacteria. How do cells 
that grow and divide enter into a temporary state of non-growth? In particular, how are the energy-
intensive processes that are required for growing cells regulated during a non-growing state? The 
main subject of this thesis is to investigate how protein synthesis, the most energy-intensive 
process in growing bacterial cells, is regulated during entry into a quiescent phenotype (stationary 
phase).   
 I first investigate how protein synthesis is regulated using a single cell method that 
fluorescently tags nascent polypeptide chains. In chapter 3, I show that during entry into stationary 
phase, protein synthesis is downregulated heterogeneously with one group of cells having 
comparatively low protein synthesis, resulting in a population that is approximately bimodal. I 
further show that this bimodality is dependent on a signaling system (PrkC and its partner 
phosphatase PrpC) that senses cell wall metabolism. I connect signaling from this system to the 
expression of an enzyme (SasA) that produces a group of nucleotides that are major regulators of 
 
 
growth in bacteria ((pp)pGpp). Lastly, I show that the bimodality is dependent on the three 
enzymes that synthesize (pp)pGpp.   
 In chapter 4, I explore in detail how the bimodality in protein synthesis is generated. This 
heterogeneity requires the production of (pp)pGpp by three synthases: SasA, SasB, RelA. I first 
show that these enzymes differentially affect this bimodality: RelA and SasB are necessary to 
generate the sub-population exhibiting low protein synthesis, whereas SasA is necessary to 
generate cells exhibiting comparatively higher protein synthesis. The RelA product (pppGpp) 
allosterically activates SasB, and I find that the SasA product (pGpp) competitively inhibits this 
activation. I provide in vivo evidence that this antagonistic interaction mediates the observed 
heterogeneity in protein synthesis. This chapter, therefore, identifies the mechanism underlying 
the generation of phenotypic heterogeneity in the central physiological process of protein 
synthesis.  
In chapter 5, I next turn to understand the biochemical mechanism by which cells with 
comparatively low levels of protein synthesis down-regulate this process. I first show that ppGpp 
is sufficient to inhibit protein synthesis in vivo. I then show that ppGpp inhibits protein synthesis 
by inhibiting translation initiation directly by binding to the essential GTPase, Initiation Factor 2 
(IF2). In collaboration with Ruben Gonzalez’s lab, we also show that ppGpp prevents the allosteric 
activation of IF2. Finally, I demonstrate that the observed attenuation of protein synthesis during 
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1.1.1 A reversable state of non-growth 
Essential to the survival of every form of life is the generation of new cells that will carry on 
the organism’s genome. Equally ubiquitous, however, are cells that do not grow or divide. These 
cells are described as either senescent and quiescent, based on their ability to re-enter into active 
growth and division. Senescence is defined as a period of terminal non-growth and division that 
occurs via direct processes that respond to damage that make a cell unable to generate new cells 
(1). For example, cells that have sustained significant damage to their telomeres or are incapable 
of repairing their telomeres due to non-functional telomerase enter into a terminal state of non-
growth and division (2). Quiescence, the other form of non-growth, describes cells that enter into 
a non-growing period, remain viable for a time, and at some point return into active cycles of 
growth and division (3). Since quiescent cells can re-enter into growth, it is only logical that the 
stimuli that send them into this state do not constitute fatal errors in the important processes for 
producing functional cells. However, the signals that cause a cell to become quiescent are less 
clear than the signals that induce senescence (4).   
Another understudied aspect of quiescent cells is their metabolic state. The conversion of 
energy and nutrients into cellular components (cell wall, proteins, nucleic acids) is of utmost 
importance for a cell to increase in size and divide (5). What is the state of these processes during 
quiescence? Quiescent cells of a wide range of organisms have low rates of active processes, which 
are required for growth, and it is widely believed that their metabolic rate is decreased compared 
to actively growing cells (6). For example, bacterial cells in quiescent states, such as during 
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nutrient limitation, have decreased ATP levels (7) and lower rates of protein synthesis (8, 9). 
Quiescence in yeast, such as occurs during nutrient deprivation, is accompanied by a decrease in 
transcription rates (10), a lowered translation rate (11), and the generation of a subpopulation of 
cells in which the cycle is arrested (12). Although quiescent cells have lowered metabolism, they 
are not believed to be completely metabolically inactive like cells that have entered into a dormant 
phenotype such as bacterial spores. That is, although they clearly have lower levels of the processes 
that require energy, they maintain these processes at lower levels, and there is evidence to suggest 
that they are necessary for quiescent cell survival. For example, inhibition of protein synthesis 
negatively affects viability of bacterial cells that have already entered into starvation induced 
quiescence (13), suggesting that although quiescent cells have lowered protein synthesis and 
metabolism, some level of these processes is still necessary.   
Presumably, it would not be advantageous for a quiescent cell to maintain a highly active 
cellular program. A cell that expends limited energy and resources and does not generate a new 
viable cell that passes on the genetic material is at a disadvantage to a cell that does. In addition, 
if a quiescent cell does not dilute newly generated cellular components through growth or division, 
then the cell has a limited volume to store them. Ultimately, unregulated accumulation of one or 
more cellular components without commensurate growth could lead to lysis of the cell. Quiescent 
cells, therefore, represent a basic biological problem: How are the energy-consuming processes of 
growing cells down-regulated upon entry into quiescence?  
1.1.2 A functional aspect of important cell types 
In addition to being universal, quiescence has been postulated to be an essential aspect of 
biology in that it serves as a regulator of exponential growth. The argument for quiescence is best 
put in terms of a simple single-celled organism. Given the growth rate of a single cell of 
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Escherichia coli (E. coli) under optimal conditions, the entire biomass of the earth would be 
quickly taken up were it not for a mechanism that limited exponential growth (14). Following this 
argument strictly, there must be a way for life to regulate its rate of expansion, or it risks using up 
all of its available resources and dies. But in any real environment, a single E. coli cell will only 
have access to a limited number of resources within spatial proximity. These resources flow in and 
out at rates that can be unpredictable. This reality again brings up the problem of unregulated 
exponential growth. A cell that uses up all the available nutrients within its vicinity may be left 
without nutrients for an undetermined period of time. For this reason, it is believed that quiescence 
is not just advantageous to survival but may be an essential mechanism of life.   
Quiescence is also a feature of cells that are important for human health. A well-studied 
example of quiescent cells is the adult stem cells (ASCs) that constitute the reservoir of human 
cells with the potential to replenish other cell types in adults. The extent to which ASCs are 
quiescent and how this contributes to their function has been the subject of major study for several 
decades (4). ASCs exist in both actively dividing and quiescent states (15), but the role of the 
quiescent reservoir of ASCs has remained unclear. Quiescence has been observed in stem cells 
that are important for the regeneration of tissues following an injury, those that are central for 
hematopoiesis, and the cells that are important for epithelial renewal (3). Recent evidence has led 
to the idea that quiescence may not just be a feature of certain stem cells but could also be an 
important determinant of how certain stem cells are able to serve as a reserve pool for actively 
dividing stem cells, especially during tissue injury (16, 17). The function of quiescence in certain 
stem cells, therefore, would be to serve as a backup to either replenish the actively dividing subset 




The emergence of antibiotic-resistant bacteria is a major topic of biological, public health, and 
economic discussion (18). Most attention has centered on the dissemination of genetic changes 
that allow specific strains of bacteria to continue to grow in the presence of the antibiotic agent 
(19). Another form of antibiotic treatment evasion occurs when a small fraction of a growing 
bacterial population stochastically enters into a quiescent phenotype with comparatively low levels 
of processes like protein translation, cell wall synthesis, transcription, and DNA replication. As a 
consequence, these cells exhibit increased tolerance to antibiotics that target active processes in 
bacterial cells. For example, if a population of cells is treated with a b-lactam (the most widely 
used class of antibiotics) such as penicillin, the penicillin will covalently bind to a group of 
essential proteins that are involved in the formation of the polymer that makes up the bacterial cell 
wall (peptidoglycan) (20). These proteins, called penicillin binding proteins (PBPs), carry out the 
transpeptidase and carboxypeptidase activity required to generate and remodel peptidoglycan (21). 
Penicillin, therefore, inhibits active bacterial cell growth. Its clinical success, however, is often 
dependent on the presence of cells with active cell wall synthesis. A cell with very little or no cell 
wall synthesis will not have active PBPs whose function can be impeded by penicillin. The 
presence of these cells within a bacterial population would therefore provide a reservoir of 
survivors cells that, if they remain viable until the antibiotic is removed, could reinstate the 
bacterial population.   
These survivor cells were first described by Bigger in 1944 (22). Bigger followed up on 
observations by Hobby et al. in 1942, who first showed that a small proportion of Staphylococcus 
aureus (S. aureus) cultures (less than 1% of cells) are able to resist treatment with penicillin (23). 
Bigger confirmed this result and further showed that upon recovery, the small number of cells that 
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survive have the same growth characteristics as the original population. That is, the cells that 
somehow survived the penicillin treatment do not exhibit a growth pattern that would suggest that 
they had acquired any genotypic difference that would account for the survival of the original 
penicillin treatment. Furthermore, when Bigger used these survivors to repopulate a bacterial 
culture and again treated with penicillin, the proportion of cells that survived the treatment was 
indistinguishable from the original experiment. This observation confirmed that the ability to 
survive the antibiotic treatment was not due to a genotypic difference between susceptible and 
survivor cells but that the difference between these cell types was phenotypic. Bigger termed this 
kind of antibiotic tolerance as bacterial persistence, and he carefully denoted the difference 
between persistent bacteria (phenotypic survivors) and resistant bacteria (genotypic survivors). 
Since these observations, persistent bacterial cells have been the subject of major study. Despite a 
large body of work, the molecular mechanisms that generate persistent cells are unclear, and no 
single mechanism(s) has been definitively shown to be essential for persister formation.     
Bigger also originally tied these phenotypic survivors to quiescence. When trying to 
understand the nature of persistent cells, Bigger tested whether persistence was affected by growth 
status in S. aureus (22). This was motivated by previous observations that suggested that penicillin 
affected cell division (24). Bigger reasoned that if persister cells were not affected by penicillin, 
then maybe their divisional status might differ from cells that died in the presence of penicillin. 
Bigger showed that cultures of S. aureus in a static (non-growing and non-dividing) state had 
higher proportions of persisters than those that were actively growing and dividing (22). Periods 
of non-growth in bacterial cultures are a ubiquitous condition called stationary phase. While 
bacteria are capable of very rapid growth (called exponential growth) when nutrients are replete, 
all bacteria enter into stationary phase in response to limiting nutrients (9). However, rather than a 
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simple exit from rapid growth as a consequence of the absence of a building block important for 
generating a new cell, stationary phase is a directed process that ensures survival in the absence of 
nutrients (9). Stationary phase is accompanied by changes gene expression as well as a reduction 
in energy intensive processes such as RNA and protein synthesis (25).  
Recent work suggests that perhaps no single mechanism is directly responsible for persistence, 
but rather that these mechanisms contribute to a cellular state that itself makes a cell transiently 
tolerant to antibiotics. In 2019 Pontes and Groisman provided evidence that certain mechanisms 
(Toxin Anti-toxin (TA) systems and (pp)pGpp) that inhibit cell growth and can increase 
persistence are not essential for the presence of tolerant cells under conditions where growth is 
already slowed. They further showed that inhibiting growth on its own using various methods is 
sufficient to increase the number of cells that survive antibiotic treatment. This led them to propose 
that slow growth itself is the mediator of persistence and that specific cellular processes are linked 
to persistence in that reduce the growth rate decrease (26).   
A complete understanding of the biology of bacterial persistence remains elusive, but the 
threat that it poses in the fight against bacterial infections is more tangible. Firstly, bacterial 
persistence is generally believed to underlie certain chronic infections, which are damaging to 
health and costly (27, 28). Mounting evidence shows that the cells from chronic bacterial infections 
exhibit slow growth like persister cells (29). Treatment of chronic infections by repeated cycles of 
antibiotic treatment can have potential consequences (30). For example, persistent cells within a 
bacterial population that survive multiple rounds of antibiotic exposure have recently been linked 




1.2.1 Role of heterogeneity 
Heterogeneity in isogenic populations of bacteria is well documented. For example, 
Pseudomonas aeruginosa (P. aeruginosa) biofilms display differential gene expression and 
antibiotic tolerance depending on where they reside within the biofilm (32, 33). B. subtilis 
developmental states, such as competence, occur in only a subpopulation of cells during stationary 
phase (34). But why is heterogeneity advantageous for the survival of bacterial populations? To 
answer this question, it is essential to thoroughly consider the native environment in which 
communities of bacteria reside.   
Unlike exponential growth in a laboratory environment, most microbial life exists in 
nutrient limited environments. Optimal growth is dependent on the right combination of nutrients 
(carbon, phosphate, nitrogen), temperature, pH, and salinity. Bacteria also face danger from 
antibiotic molecules (either generated by other organisms or those applied clinically). Furthermore, 
infection by phage is a major threat to all bacteria outside of the laboratory. A bacterial cell that 
does not accurately adjust to a change in any of these environmental factors not only risks being 
at a disadvantage to ones that do but even losing viability altogether. Furthermore, environmental 
conditions are unpredictable and can cycle between being optimal for growth to poorly sustaining 
life at inconsistent rates. For example, rapid and slow growth can both be advantageous for bacteria 
infecting a human host depending on whether antibiotic treatment is applied. But a bacterial 
community has no way to predict if this will be the case. An alternative strategy for a group of 
isogenic cells is to display both slow and fast growing phenotypes. This way, some members of 
the community will be well adapted to any situation. This hypothesis is backed up by simulations 
of bacterial assemblages, which show that a population of isogenic cells can actually achieve a 
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higher net growth rate by generating heterogeneity under fluctuating  environmental conditions 
(35).   
Mounting evidence suggests that heterogeneity is advantageous in clonal bacterial 
populations (36, 37). But is phenotypic heterogeneity achieved passively, as a result of imprecise 
systems, or do direct mechanisms mediate the generation of heterogeneity? It is unlikely that a 
single biological mechanism could be so precise as to yield a distinct output with very low variance 
when applied to a population of thousands to millions of cells (38). This biological variance could 
itself generate groups of cells that differ slightly from each other, and if the system is imprecise 
enough, then the cells on either extreme could display significantly different phenotypes(38). But 
more extreme forms of heterogeneity exist. For example, populations of isogenic bacteria often do 
not display phenotypes centered around a single mean but rather two.   
1.2.2 Bimodality 
Bimodal distributions of gene expression and physiological state are readily observable in 
bacteria. One common example, which I have already discussed, is antibiotic persistence. When 
Bigger first explained tolerance to penicillin by a small number of cells within a population of non-
resistant cells, he also presented the first piece of evidence that temporary tolerance to antibiotics 
is, on a population level, bimodal. He noted that in cultures of S. aureus treated with penicillin, 
not only do most cells die and a few survive, but also that the rate of death occurred in a biphasic 
fashion. That is, whereas most of the cells (99% of the population) died within the first 6 hours, 
the rest of the population died over a much larger time window (over 72 hours). This evidence, 
which has been confirmed many times since then, suggests that on a population level, tolerance to 
penicillin is bimodal. This phenomenon was confirmed 60 years later, and bacterial persistence 
has now been shown to be a phenotypic switch (39).    
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Bimodal phenotypes arise from mechanisms that display bi-stability in which either of two 
extremes represents a more energetically stable state than the ones that lie between these two states. 
For example, in Bigger’s experiments, cells were either susceptible to penicillin or tolerant to it. 
How does biology generate bistable systems? Two mechanisms have been identified that generate 
bimodality in isogenic populations (40, 41). The first involves a master regulator whose activity is 
auto-activated in a non-linear fashion. The nonlinearity of activation allows for a small change in 
concentration of the master regulator to provide two vastly different outputs. This kind of 
regulation has been experimentally validated using a gene regulation circuit in Saccharomyces 
cerevisiae (S. cerevisiae), where a graded increase in a transcriptional activator can provide a 
binary response in GFP production if the transcriptional activator activates not only GFP 
transcription but also its own transcription (42). The second mechanism involves two mutually 
repressive repressors. The first repressor (R1) is inactivated if the second repressor (R2) is present. 
If R2 becomes inactivated for any reason, such as due to an external stimulus, then the expression 
of R1 is turned on. R1 then stimulates expression of itself. Finally, since R1 represses R2 
expression, once R1 expression reaches a certain point, then the system tends to stay in an R1 ON 





Figure 1.1 Mutually repressing repressors. Bistability in gene expression can be the product of a 
gene network where two genes act as repressors of each other. Expression of the first repressor, 
R1 is controlled by the second repressor R2 and vice versa. So under conditions where R2 is 
expressed, R1 expression is inhibited, and R2 expression is therefore de-repressed. If, for some 
reason, such as because of an external stimulus, R2 expression decreases, then R1 expression 
increases. At some point, the buildup of R1 is able to repress R2 expression, and R2 concentration 












An example of this mechanism is the switching between lysogeny and lysis in phage l 
(43). During l phage infection of E. coli, the bacteriophage decides to either enter into a lysogenic 
phase where it is integrated into the host chromosome or to initiate a lytic program that involves 
replication of its genome and eventual phage particle production by the host E. coli cell. Both 
lysogeny and lysis are stable states that both repress the progress of the other state. Lysogeny is 
maintained by the CI repressor, which inhibits transcription of the genes that are essential for lysis 
and promotes transcription of CI itself as well as lysogeny specific genes, including the lysis 
promoting cro. If, under certain circumstances, the CI repressor becomes inactivated, then 
expression of the lysis promoting Cro increases. Cro production stimulates expression of itself and 
lysis specific genes. Cro also represses CI repressor production, which further promotes induction 
of Cro and lytic genes. CI and Cro, therefore, represent mutually repressive repressors and these 
two proteins mediate the switch from lysogeny to lysis in l phage (43).  
Either of the two systems discussed above (self-activating master regulator and mutually 
repressive repressors) can mediate switching in bacterial populations. How are these controlled? 
Specifically, how does the concentration of the master regulator become upregulated past the 
tipping point? How does R2 become inactivated? 
1.2.3 Types of switching 
In theory, two extreme systems could control phenotypic switching. The first, responsive 
switching, describes mechanisms that generate heterogenous populations of isogenic cells in 
response to environmental stimuli. This kind of heterogeneity could theoretically allow a 
population to maximize growth when conditions are favorable by exploiting the replicative power 
of every single cell. Upon sensing that conditions are not sufficient to sustain growth of all cells, 
the community of cells would then switch to generate phenotypic heterogeneity. In order for this 
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type of switching to provide maximal advantage, however, ample time is required for the 
population to generate heterogeneity.    
The second kind of switching, spontaneous stochastic switching, occurs in the absence of 
an environmental cue. That is, the heterogeneity is intrinsic to the population. Unlike responsive 
switching, this form of heterogeneity sacrifices the growth of certain members of the population 
even in the absence of any signal that would communicate to the population that heterogeneity 
would be advantageous. But, this sacrifice provides an important advantage in the form of the 
ability to very quickly deal with a very fast-changing environment. Unlike responsive switching, 
stochastic generation of variants preemptively provides the population with a reservoir of cells that 
can survive a rapid change in environmental conditions. For this reason, stochastic switching has 
been shown through modeling and simulation to be advantageous compared to responsive 
switching in a dynamic environment (44). 
1.2.4 Sources of switching: Noise 
As described above, switching between different phenotypes occurs stochastically, and this 
has been linked to either expression of a gene that acts to upregulate its own activity in a non-
linear fashion or by expression of two mutually repressive repressors. Both of these mechanisms 
translate small changes in the expression of master regulators into bistable gene expression. But 
what causes the initial small variation? A degree of variance in the expression of any given gene 
product is a general characteristic of gene expression. The synthesis of an mRNA from a DNA 
template, followed by the translation of this mRNA into a protein, are all processes that are carried 
out by the biochemical activity of a relatively small number of enzymes (45). The low abundance 
of these enzymes means that even small variations in their absolute numbers between two cells 
can result in a noticeable difference in the expression of a gene in these two cells (46, 47). In 
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addition, their fidelity in carrying out a biochemical process is not perfect (48). The variance that 
both of these aspects of gene expression provide to heterogeneity between cells is termed noise 
and has been observed in systems including phage infection (49), lac operon regulation (50), and 
chemotactic swimming (51).   
Two basic types of noise exist in gene expression. The first, intrinsic noise, refers to noise that 
occurs as a part of the randomness of the biochemical reactions that are a part of gene expression, 
such as binding of a transcription factor to a DNA element. Intrinsic noise in gene expression 
manifests itself as randomness that is not specific to a given gene. That is, if a cell had two genes 
under the same expression control (identical promoters), intrinsic noise would cause the levels of 
each gene to not be highly correlated even though they are under the same control. The second, 
extrinsic noise, affects gene expression in a manner that is not specific to a particular gene. This 
kind of noise arises from differences in the abundances of cellular components that are important 
for gene expression, such as RNA polymerase (46). Differences in extrinsic noise would cause the 
same two genes above to have expression levels that were highly correlated. Both of these types 
of gene expression have been found to be physiologically relevant experimentally, and both 
contribute significantly to heterogeneity in cells (52). Furthermore, noisy gene expression has been 
observed throughout the genome in E. coli (53). Intrinsic noise could explain the differences that 
give rise to stochastic switching that is observed in bacteria populations. But the ability to regulate 
the level of noise in response to specific stimuli is an appealing feature of extrinsic noise from an 
evolutionary standpoint. Importantly, both forms of noise are subject to selection via evolution, 
but extrinsic noise could adjust the level of heterogeneity in a population in response to a stimulus 




1.3 Signaling through membrane bound kinases 
1.3.1 Sensing of environmental conditions 
As I discussed above, bacteria live in environments that often provide unpredictable 
amounts of nutrients and other factors that are necessary for growth. For this reason, mechanisms 
that sense the environment are essential for survival. The most well-studied sensory mechanisms 
used by bacteria involve transduction of a signal through two-component systems (TCS) (54). The 
basic architecture of a TCS involves a sensor protein, whose activity is stimulated by a specific 
stimulus, and a response regulator that carries out the cellular function appropriate for the 
environmental condition (54). The sensor modifies the response regulator and therefore changes 
its activity. The prototypical sensor is a histidine kinase that auto-phosphorylates on a conserved 
histidine residue in response to a specific signal (54). This phosphorylation is followed by transfer 
of this phosphoryl group to its corresponding response regulator. The phosphorylation on the 
response regulator occurs on a conserved aspartate residue on a signal receiver domain that 
activates an output domain that mediates an appropriate cellular function. The response regulator 
is typically a DNA-binding protein, and phosphorylation affects DNA binding resulting in 
transcriptional changes (54). Many sensor kinases are bi-functional, meaning they mediate the 
addition and removal of the phosphoryl group from the response regulator (54).   
1.3.2 eSTKs in bacterial sensing  
Signaling through histidine and aspartic phosphorylation by TCSs was assumed to be the 
only form of phosphorylation-based signaling in bacteria. This notion was upended when a protein 
kinase (Pkn1) with the ability to auto-phosphorylate on a serine residue was discovered in 
Myxococcus xanthus (M. xanthus)(55). Pkn1 is also essential for the formation of fruiting bodies, 
a developmental state that M. xanthus undergoes in response to nutrient deprivation. Since this 
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original observation, eSTKs have been identified in many different species, and they are now 
believed to be ubiquitous in bacteria. Similar to the TCSs, eSTKs have a diverse set of functions 
in bacteria. These include sensing and regulating cell wall synthesis and cell division in important 
human pathogens like Mycobacterium tuberculosis (M. tuberculosis) (56) and Streptococcus 
pneumoniae (S. pneumoniae) (57).   
1.3.3 eSTKs as a means of regulating cellular programs 
eSTKs are also important for a developmental state in the Gram-positive model organism 
Bacillus subtilis that occurs in response to nutrient deprivation (58). Under nutrient limitation, B. 
subtilis enters into a developmental state, sporulation, where a dormant cell, the spore, that is 
highly resistant to physical stress is generated. Spores survive in non-optimal environments and 
can remain viable > 100 years (59). Although spores do not grow or they divide, they retain the 
capability to re-enter into a vegetative state through a process called germination (60) that occurs 
in response to specific environmental cues that signal to the dormant cell that re-growth could be 
advantageous. Spores have the capability to germinate in response to nutrients availability. For 
example, L-alanine is a well-known germinant for B. subtilis spores (61). 
B. subtilis spores also sense the growth of other bacteria, which serves as an indirect 
measure of nutrient availability. Specifically, they sense muropeptides derived from the cell wall 
peptidoglycan. In order for a cell to grow in size and divide, it must generate and remodel its cell 
wall, a mesh-like extracellular structure composed of peptidoglycan, a polymer of crosslinked 
glycan strands, that provides the necessary rigidity to maintain shape in the presence of turgor 
pressure. Remodeling of the cell wall during growth and division is accomplished by a group of 
proteins that insert and crosslink new peptidoglycan and hydrolyze old peptidoglycan in order to 
either grow the cell or aid in division (58). As a result, cell wall fragments (muropeptides) are 
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released into the environment (59). Since muropeptide release occurs during bacterial growth and 
division, environments where cells are growing contain relatively high levels of these molecules.   
B. subtilis spores exploit this fact in order to decide when to germinate. Specifically, B. subtilis 
spores express an integral membrane eSTK called PrkC that senses muropeptides (60). PrkC is a 
PASTA (Penicillin and Ser/Thr Kinase Associated) -domain-containing eSTK (60) where the 
cytoplasmic kinase domain is connected via a membrane-spanning domain to the extracellular 
PASTA domain that binds peptidoglycan fragments (61). B. subtilis spores germinate in response 
to fragments of cell wall from diverse species in a PrkC dependent manner, suggesting that in 
spores, PrkC serves to sense fragments of bacterial cell wall that growing bacteria have shed in 
order to signal to the dormant cell that conditions are favorable for growth (60).   
During peptidoglycan induced germination, PrkC phosphorylates EF-G, the essential 
translational GTPase involved in translocation of ribosomes on mRNAs (60). In growing cells, 
PrkC interacts with the essential B. subtilis WalRK TCS that controls expression of genes that are 
important for cell wall metabolism (62). WalK phosphorylates WalR on Asp-43, and, in addition 
PrkC also phosphorylates WalR on Thr-101 (63). This secondary phosphorylation affects the 
binding of WalR to DNA and affects expression of genes in its regulon (64). One of these genes 
is particularly interesting because its gene product is a protein that has been suggested previously 
to induce dormancy by generating a nucleotide second messenger (SasA). Intriguingly, expression 
of sasA is heterogeneous and is subject to extrinsic noise (64). 
Phosphorylation through eSTKs also has a direct effect on energy-intensive mechanisms that 
are important for growth. During sporulation in B. subtilis, a growing cell generates a dormant 
spore that must undergo a shut-down of energy-intensive processes. For example, inhibition of 
protein synthesis via phosphorylation of an essential translation factor has been shown to be 
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important to effectively generate dormant spores (65). This inhibition is dependent on a 
sporulation-specific eSTK (YabT). YabT phosphorylates the translation factor Elongation Factor 
Tu (EF-Tu) that mediates delivery of aminoacylated tRNAs to the ribosome. Phosphorylation of 
EF-Tu inhibits its ability to hydrolyze GTP, preventing its release from the ribosome, thereby 
inhibiting the cycles of elongation that are necessary for protein synthesis. Interestingly, ablation 
of EF-Tu phosphorylation in B. subtilis (via deletion of the eSTKs that can phosphorylate EF-Tu) 
results in cultures where a higher proportion of spores show hallmarks of spontaneous germination 
compared to wildtype (65).   
1.4 Differentially phosphorylated guanosine nucleotides  
1.4.1 Nucleotide second messengers 
As discussed above, kinase-dependent signal transduction can alter the cellular program by 
phosphorylation of key proteins. But is signal transduction through kinases restricted to post-
translational modifications? More specifically, phosphorylation of translation factors can affect 
rates of protein synthesis during entry into quiescence. But how does signaling through these 
kinases communicate this information to the other cellular programs? A common theme in signal 
transduction is the production of nucleotide second messengers. Nucleotide second messengers 
have been the subject of study since the early 1950s when it was demonstrated that cyclic 3’5’ 
adenosine phosphate (cAMP) mediates the metabolic changes in eukaryotic cells as a response to 
hormone exposure (66). Sutherland and colleagues published a series of papers that identified that 
the activity of one of the enzymes responsible for breaking up glycogen (glycogen phosphorylase) 
was upregulated when cells were exposed to the hormones epinephrine and glucagon (67, 68). The 
link between hormone exposure and phosphorylase activity was the presence of a small cyclic 
nucleotide (cAMP) which would later be found to be a major second messenger molecule in both 
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eukaryotic and prokaryotic organisms. In bacteria, cAMP mediates catabolite repression, the 
mechanism by which bacteria preferentially utilize one carbon source by shutting off expression 
of genes required to utilize other carbon sources (69). Around the same time, important work on 
another nucleotide second messenger was also emerging. The nucleotides (pp)pGpp have similarly 
been the subject of major study in bacterial physiology. These nucleotides have been shown to be 
major regulators of growth in bacteria and play a central role in communicating availability of 
nutrients to energy-intensive processes.   
1.4.2 History of (pp)pGpp 
 In 1952, Sands and Roberts demonstrated that bacterial cells coordinate the synthesis of 
important macromolecules (70) by observing a concomitant decrease in the synthesis of RNA 
when cells were starved for certain amino acids. This discovery, termed the stringent response, led 
to the identification of how and why RNA and protein synthesis was linked. An important advance 
was the identification of a strain that did not exhibit this tight regulation (71). This strain was found 
using mutations that accumulated as E. coli was adapted to a laboratory environment and allowed 
Stent and Brenner to identify the genetic determinant of this control (the “RC gene”) (72). The 
mechanism by which this gene brought about the observed link between amino acid starvation and 
RNA synthesis, however, remained unknown. Cashel and Gallant observed that upon amino acid 
starvation, not only the synthesis of RNA but also the synthesis of phosphorylated species, 
including nucleoside triphosphates, was altered in an RC gene-dependent fashion. (73). They 
postulated that the link between decreased RNA synthesis and amino acid starvation was mediated 
by a molecular inhibitor that also restricted metabolic functions generally and that this inhibitor 
was the product of the RC gene. Deciding to investigate phosphorylated species, they observed the 
presence of two molecules that accumulated when cells were starved of amino acids in an RC 
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gene-dependent fashion. These molecules were termed “magic spots” and opened up a field of 
investigation on the control of metabolic functions in cells undergoing starvation conditions. The 
two magic spots were soon after described as two phosphorylated guanosine nucleotides, 
guanosine 5’triphosphate 3’diphosphate and 5’diphosphate 3’diphosphate ((pp)pGpp)) (74).   
Although more than 50 years have passed since (pp)pGpp was originally observed, many 
questions still remain regarding its role in cellular physiology. For example, a role for (pp)pGpp 
in translation has been suggested and in vitro evidence exists that (p)ppGpp interacts with essential 
components of this process, direct in vivo evidence has not been reported (75, 76). This is due, in 
part, to the methods used to analyze (pp)pGpp that rely on inducing amino acid starvation in 
exponentially growing cells and thereby directly inhibit translation. Specifically, although 
(pp)pGpp was originally identified when cells were shifted to amino acid free media, the field soon 
moved to using molecular inhibitors of tRNA charging, such as serine hydroxamate (77). These 
inhibitors simulate amino acid starvation and thereby also inhibit protein synthesis directly (78). 
While this treatment efficiently increases cellular (pp)pGpp, it precludes any observation of 
(pp)pGpp’s effects on translation. Recently, (pp)pGpp synthetases have been identified in Gram-
positive bacteria whose activity is controlled transcriptionally and is not dependent on amino acid 
starvation (79). As I will discuss, these findings make it possible to study the effects of (pp)pGpp 
under conditions not intrinsically limiting for protein synthesis.   
1.4.3 Synthetases and the different nucleotides 
Not all bacteria possess an equal breadth of (pp)pGpp synthetic enzymes. Gram-negative 
bacteria generally possess one long-form RelA/SpoT homologs (RSH) (with the exception of b 
and g proteobacteria which have two-long form RSHs), whereas Gram-positive bacteria typically 
have a single bi-functional RSH enzyme and two small alarmone synthetases (SAS) (80). In most 
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bacteria, one of the long-form RSH enzymes is ribosome-associated, and it directly senses 
deacylated tRNAs in the A site of the ribosome (80). Specifically, in E. coli, RelA binds the 
deacylated tRNA by wrapping around the tRNA via its C terminus, which contains flexible arms 
that allow it to cradle the tRNA in the A-site of the ribosome (81). RelA also directly contacts the 
acceptor arm of the tRNA via its TGS domain and directly senses if the tRNA is uncharged (81). 
Binding of an uncharged tRNA in the A-site stimulates RelA to make (pp)pGpp via its synthetase 
domain, which lies at the N-terminus of the protein (Figure 1.2 B) (81). Unlike the RSH proteins, 
SAS enzymes are believed to be regulated transcriptionally, and they lack the accessory domains 
that are essential for RelA to associate with the ribosome and sense amino acid starvation (Figure 
1.2 B) (80). In B. subtilis the long-form RSH, RelA, is the mediator of the stringent response, and 
RelA produces (pp)pGpp in response to deprivation of amino acids (Figure 1.3A) (82). The role 
of the SAS enzymes has been postulated to either fine-tune the stress response mediated by RelA 
or to respond to different environmental cues (80).  
In Gram-positive bacteria the SAS proteins have been associated with cell wall stress. In B. 
subtilis expression of one of these enzymes, SasA is induced in response to treatment with 
antibiotics that inhibit cell wall synthesis (Figure 1.3C) (83). Similarly, both of the S. aureus SAS 
enzymes (RelP and RelQ) are induced by cell wall active antibiotics (84). These enzymes are also 
important for survival during cell wall stress because deletion of both of these enzymes negatively 
affects viability during exposure to vancomycin (84). One of the SAS enzymes has also been 
suggested to be a sensor for single-stranded RNA (ssRNA). The SAS1 enzyme of multiple species 
(B. subtilis SasB and E. faecalis RelQ) are active as homo-tetramers, and this tetramerization forms 
two allosteric binding sites for (pp)pGpp (85, 86). Both enzymes are allosterically activated by 
pppGpp, but this allosteric activation seems to depend on the presence of a ssRNA with a Shine-
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Delgarno-like sequence (GGAGG) in the E. faecalis RelQ enzyme (86). This has led to the 
proposition that RelQ (SasB in B. subtilis) serves as a sensor for ssRNA but whether this is 






Figure 1.2 RSH enzymes but not SAS enzymes interact with the ribosome (Reproduced from 
Brown et al. Nature 2016). (A) Structural view of E. coli RelA in complex with a starved ribosome 
showing the interaction between the C-terminal domain of RelA with the uncharged tRNA (purple) 
in the A site of the ribosome. The C-terminal domain of RelA cradles the A-site tRNA and the 
TGS domain of RelA contacts the tRNA acceptor arm. (B) Ribbon structure of ribosome bound 
E.coli RelA depicting the N-terminal hydrolase domain (navy) and synthetase (red) and the tRNA 
contacting TGS (dark green) and the C-terminal domains that cradle the tRNA in the A-site. (C). 
Domain architecture of RSH enzymes compared to the SAS enzymes. Whereas the RSHs are bi-
functional proteins with N-terminal hydrolase and synthetase domains and C-terminal domains 
that interact with ribosome associated uncharged tRNAs, SAS enzymes lack both hydrolase 










Figure 1.3. B. subtilis (pp)pGpp synthetases respond to different signals and generate different 
molecules. (A) B. subtilis RelA is the mediator of the stringent response and generates a 
pentaphosphorylated guanosine nucleotide (pppGpp) in response to amino acid starvation. (B) One 
of the Gram positive specific SAS enzymes present in B. subtilis, SasB, primarily generates a 
tetraphosphorylated guanosine nucleotide (ppGpp) and has been postulated to be a sensor of 
ssRNA because allosteric activation is inhibited by ssRNA, although the physiological relevance 
of this is not known. (C) The other SAS enzyme in B. subtilis, SasA, preferentially generates a 5’ 
monophosphate 3’ di-phosphate guanosine and its expression is stimulated under conditions of 
















Apart from the breadth of enzymes which generate (pp)pGpp, the specific role of each of these 
closely related guanosine nucleotides is a topic of recent investigation. In B. subtilis, each 
(pp)pGpp synthetase preferentially generates a particular closely related nucleotide. The rationale 
for the presence of several closely related guanosine molecules is yet to be fully understood. Gram-
negative bacteria have been known to generate approximately equal amounts of the tetra- and the 
penta-phosphorylated guanosines (82). In contrast, B. subtilis primarily generate the penta-
phosphorylated form in response to amino acid starvation by the action of the RSH protein RelA 
using GTP and ATP as substrates (Figure 2A) (82). B. subtilis SasB (yjbM), preferentially utilizes 
GDP and ATP to generate the tetra-phosphorated guanosine in vivo (Figure 2B) (79). B. subtilis 
SasA generates a 5’ monophosphate 3’ di-phosphate guanosine (pGpp) using GMP and ATP as 
substrates in vitro and in vivo (Figure 2C) (79). pGpp was recently shown to be an alarmone in B. 
subtilis with distinct function to both ppGpp and pppGpp (87). Both the tetra- and penta-
phosphorylated guanosines interact GTPases that control ribosome biogenesis, translation, and 
with proteins involved in regulation of purine nucleotide biosynthesis (87). pGpp, however, seems 
to interact with proteins involved in purine biosynthesis. Furthermore, an enzyme (NahA) that 
generates pGpp using both ppGpp and pppGpp is involved in the regulation of recovery from 
nutrient downshift because cells that lack this enzyme take longer to begin growth following re-
addition of nutrients (87).   
1.4.4 Role in regulating energy intensive processes  
When amino acids are scarce, bacterial populations enter into a quiescent phenotype known 
as stationary phase. During stationary phase, bacterial growth halts, and cell division pauses. The 
bacterial response to nutrient deprivation has been linked to (pp)pGpp that directly binds and 
inhibits key proteins which catalyze energy-intensive processes, including transcription via 
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binding of the Gram-negative RNA polymerase (88, 89), GTP biosynthesis (via binding to the 
GTP biosynthetic enzymes HprT and GmK) (90), DNA replication (via binding to DNA primase) 
(91), ribosome assembly (via binding to several ribosome assembly factors including ObgE and 
RsgA) (92).  
(pp)pGpp can also bind translational GTPases (93). However, other than several early, 
intriguing in vitro observations (94, 95), much less attention has been paid to the large number of 
fully formed active ribosomes and if a direct (pp)pGpp-dependent mechanism inhibits their 
activity. Furthermore, although myriad translational- and ribosome-associated GTPases have been 
shown in vitro to be inhibited by (pp)pGpp, the identification of a verified in vivo target and its 
role during quiescence related attenuation requires further study. 
1.5 Protein synthesis 
1.5.1 Translation as a regulatory step 
Of the energy-intensive processes in a growing bacterial cell, protein synthesis utilizes the 
most energy. Specifically, during active growth in E. coli, protein synthesis consumes ~60 percent 
of the ATP that is generated (5). Because of this, regulation of translation, the most energy-
intensive portion of protein synthesis (96) is an important regulatory mechanism during entry into 
quiescence (65). Translation proceeds in four general steps: initiation of a peptide chain, elongation 
of this peptide as coded by an mRNA, termination of the peptide, and recycling of the ribosome. 
Of these steps, the inhibition of initiation has been shown to be a common form of translational 
regulation (97). In eukaryotes, this occurs via phosphorylation of the initiation GTPase, which 
mediates binding of tRNAmet to the ribosome, eIF2. This phosphorylation inhibits its ability to be 
released from the ribosome and globally shuts off translation (97). It has also been suggested, but 
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not demonstrated, that inhibition of initiation occurs during nutrient deprivation in bacteria via 
direct inhibition of the bacterial GTPase involved in initiation (Initiation Factor 2, IF2) (75).   
1.5.2 Initiation 
During bacterial translation initiation, the ribosome must correctly bind to a region of an 
mRNA upstream of the gene to be translated. The most common motif is called a Shine-Delgarno 
(SD) sequence consisting of a sequence of conserved nucleotides located 8-10 nucleotides 
upstream of the start codon (98). The SD is important for recognition of the ribosome binding site, 
and interactions between a complementary sequence in the 16S ribosomal RNA (the anti-SD) are 
important for recruitment of the 30S ribosomal subunit (98). This recognition and binding of the 
ribosome to the RBS occur as soon as the ribosome binding site is transcribed as transcription and 
translation are linked in bacteria via physical linkage between the ribosome and RNA polymerase 
(RNAP) (98). Accurate initiation is also promoted by the bacterial Initiation Factors 1, 2, and 3 
(IF1/2/3) (98). The first of these, IF1 helps to promote the binding of IF2 and IF3 (98). IF2, a 
GTPase with homologous function to the eukaryotic initiation factor 5B (eIF5B), helps to recruit 
the initiator tRNA (fMet-tRNAfMet) (98). This tRNA is specifically used to carry a modified 
methionone (N-Formylmethionine) which is required to initiate a peptide chain (98). The third 
initiation factor (IF3) functions to provide fidelity of recognition of this specific tRNA (98). If the 
initiator tRNA is not associated, IF3 interferes with the final step of translation initiation 
(association of the ribosomal subunits) (98).   
At the beginning of initiation, the 30S subunit, all three initiation factors, and the fMet-
tRNAfMet form a 30S preinitiation complex (30S PIC) (98). The three factors and the fMet-
tRNAfMet do not need to bind to the 30S subunit in a particular sequence (98). However, from a 
kinetic standpoint, the following sequence is preferred (98). First IF3 binds to the 30S, followed 
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by IF2, IF1, and finally, the fMet-tRNAfMet (98). The binding of the fMet-tRNAfMet is sometimes 
preferentially through a complex consisting of GTP, IF2, and fMet-tRNAfMet, but this is not 
essential (98). The unstable 30S PIC requires recruitment of an mRNA in order to form the more 
stable 30S initiation complex (30S IC) (98). This binding can occur to the 30S ribosome at any 
time regardless of initiation factors but, 30S IC formation requires all the factors to be present (98). 
30S IC formation allows for the recruitment of the large ribosomal subunit (50S), and the binding 
of the 50S to the 30S IC brings about the disassociation of the initiation factors (98). During this 
step, the fMet-tRNAfMet must be correctly accommodated in the peptidyl-site (P-site) of the 
ribosome (98). The disassociation of the initiation factors signifies the formation of the mature 
ribosome (70S) (98).   
1.5.3 Elongation, termination, and recycling 
The next steps of translation involve elongation of a peptide chain, translocation of the 
ribosome down the message, termination of the peptide chain, and finally recycling of the 
ribosome. Importantly, both elongation and translocation are energy-intensive processes that 
require repetitive cycles of association and then subsequent release of essential and universally 
conserved GTPases. During elongation, GTP bound EF-Tu delivers the amino acylated tRNAs to 
the ribosome so that these may be added to a growing peptide chain. Once a new amino acid has 
been added to the peptide chain, the ribosome must translocate down the mRNA. This is mediated 
by GTP bound EF-G, which binds the ribosome, and upon translocation and GTP hydrolysis 
releases from the ribosome. Recent research on elongation, termination, and recycling is reviewed 
in detail in (98) but will not be the main subject of this thesis, so they will not be covered in depth 
here.    
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1.6 Scope of this thesis 
In this thesis, I will explore how protein synthesis, the most energy-intensive process in a 
bacterial cell, is regulated during the transition from active growth to stationary phase. I begin by 
observing rates of protein synthesis using a fluorescent probe that allows single-cell analysis of 
protein synthesis. Using this method, I first identify that populations of B. subtilis entering into 
stationary phase displays a bimodal distribution of protein synthesis (Chapter 3). Specifically, two 
populations arise, one with low rates of protein synthesis and one with comparatively higher rates. 
This bimodality suggested that an active mechanism mediated the shutdown in protein synthesis, 
and I proceed to explore that possibility in Chapter 4. I provide evidence that the shutdown in 
protein synthesis is mediated by a sensing system that is responsive to changes in cell wall 
synthesis. I further connect sensing through this system to the production of the nucleotide second 
messengers (pp)pGpp and show that the (pp)pGpp is essential for the heterogeneity observed. I 
continue to dissect the heterogeneity and show that crosstalk between two closely related 
guanosine nucleotides (pGpp and pppGpp) regulates the allosteric production of a third of these 
nucleotides (ppGpp) and that this crosstalk mediates the bimodality observed in protein synthesis. 
Lastly, I define a molecular mechanism by which ppGpp directly inhibits translation initiation and 
show that this mechanism mediates the shutdown in protein synthesis during entry into stationary 






2 Materials and Methods 
2.1 B. subtilis Bacterial Strain construction  
B. subtilis strains generated in this thesis are all derived from the wildtype lab strain 168 
(trpC2). All strains and transformation were grown in the presence of L-tryptophan (at least 50 
µg/mL L-tryptophan). All strains were all generated by integrating plasmids, PCR products, or 
genomic DNA containing homology to a specific region of the wildtype B. subtilis chromosome 
using standard lab protocols. Briefly, B. subtilis strains are made competent by picking individual 
colonies grown overnight at 37 °C into 2 mLs SpC media (1X Tbase, 1% glucose, 0.036% MgSO4, 
0.4% Yeast Extract, 0.05% Casamino acids, 53.5 µg/mL L-tryptophan) and grown at 37 °C on a 
roller drum for 4 hours.These cultures were then transferred to 20 mLs of SpII media (1X Tbase, 
0.5% glucose, 0.5mM CaCl2, 0.000084% MgSO4, 0.15% Yeast Extract, 0.01% Casamino acids, 
80 µg/mL L-tryptophan) and grown at 37 °C on a water bath shaker for 1.5 hours. The entire 
culture was then spun down at 3K RCF for 10 minutes. The supernatant was transferred to a sterile 
container and cell pellets were re-suspended in 1.5 mLs of this supernatant. 300 uL of 50% glycerol 
was added and cells were aliquoted in 200 µL and frozen and stored at -80 °C.   
B. subtilis competent cells were transformed by growing 100 uL of cells with 100 uL of SpIIE 
media (1X Tbase, 0.5% glucose, 0.084% MgSO4, 0.1% Yeast Extract, 0.01% Casamino acids, 2 
mM EGTA, 100 µg/mL L-tryptophan) and either 1 µL of purified plasmid DNA, 5 µLs of gel 
purified PCR products, or 1 µL of 1:100 diluted gDNA. Cells were incubated on a roller drum for 
40 mintues at 37 °C and plated on an antibiotic plate for selection. Plates were grown overnight at 
37 °C and single colonies were picked and re-streaked to single colonies. Single colonies from re-
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streak plates were grown in LB without selection overnight at 37 °C and strains were stored at -80 
°C in 25% glycerol.   
2.2 B. subtilis Growth curves 
Growth curves were performed in a Tecan Infinite m200 plate reader at 37 ºC with continuous 
shaking and OD600 measurements were made every five min. Cultures were grown from single 
colonies from fresh LB plates grown overnight at 37 ºC. Exponential phase starter cultures (OD600 
~ 0.5 - 1.5) were diluted to OD600 = 0.01 and grown in 96-well Nunclon Delta surface clear plates 
(Thermo Scientific) with 150 µL per well. All growth curves were done in triplicate and media-
only wells were used to subtract background absorbance. 
2.3 OPP labeling 
Click-iT Plus OPP Protein Synthesis Assay Kit (Invitrogen) was used to label cells with OPP 
following manufacturer’s instructions. 450 µL of cells at given time points were transferred to 
disposable glass tubes. OPP was added to a final concentration of 13 µM. Labelling was performed 
at 37 ºC on a roller drum for 20 min and all subsequent steps were done at RT. Cells were harvested 
by centrifugation at 16K RCF for 1 min and re-suspended in 100 µL of 3.7% formaldehyde in PBS 
for fixation. Cells were fixed for 10 min, harvested, and permeabilized using 100 µL of 0.5% 
Triton X-100 in PBS for 15 min. Cells were labelled using 100 µL of 1X Click-iT cocktail for 20 
min in the dark. Cells were harvested and washed one time using Click-iT rinse buffer and then 
re-suspended in 20-40 µL of PBS for imaging or in 150 µL of PBS for fluorescence measurement 
on a Tecan Infinite m200 plate reader in 96-well flat bottom White sided plates (Greiner Bio-One). 
Images were analyzed using Image J.   
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2.4 HPG labeling 
Click-iT Plus HPG Alexa Fluor 488 Protein Synthesis Assay Kit (Invitrogen) was used to label 
cells with HPG following manufacturer’s instructions. 450 µL of cells were transferred to 
disposable glass tubes. HPG was added to a final concentration of 60 µM. Labelling was performed 
at 37 ºC on a roller drum for 20 min and all subsequent steps were done at RT. Cells were harvested 
by centrifugation at 16K RCF for 1 min and re-suspended in 100 µL of 3.7% formaldehyde in PBS 
for fixation. Cells were fixed for 10 min, harvested, and permeabilized using 100 µL of 0.5% 
Triton X-100 in PBS for 15 min. Cells were labelled using 100 µL of 1X Click-iT cocktail for 20 
min in the dark. Cells were harvested and washed one time using Click-iT rinse buffer and then 
re-suspended in 150 µL of PBS for fluorescence measurement on a Tecan Infinite m200 plate 
reader in 96-well flat bottom White sided plates (Greiner Bio-One).  
2.5 HADA labeling 
HADA probe was used to label active cell wall synthesis throughout growth. 450 µL of cells 
were transferred to disposable glass tubes and 2.25 µL of 100 mM HADA stain was added.  Cells 
were grown at 37° C in roller drum for 20 minutes. Cells were pelleted at 16K RCF for 1 minute 
and cells were then washed one time with 500 µL of 1X PBS. Cells were again pelleted at 16K 
RCF for 1 minute and pellets were resuspended based on OD600 (10 uLs for log phase, 40-50 uL 
for transition phase and stationary phase. 10µL of cells were spotted on an agar pad and images 
were taken on microscope using phase contrast and DAPI filters.   
2.6 sasB transcriptional reporter cloning  
sasB transcriptional reporter strain was constructed essentially as described in (64). Briefly, a 
107 bp region encompassing the sasB operon promoter (PsasB) was amplified and inserted into 
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AEC 127 using EcoRI and BamHI sites. The resulting AEC 127 PsasB was integrated into B. subtilis 
168 trpC2 at sacA. 
2.7 F42A SasB strain construction 
sasBF42A strain was generated using integration of a pMINIMAD2 derivative (pMINIMAD2 
sasBF42A). Briefly, sasB was amplified excluding start and stop codons and the F42A mutation was 
introduced using overlap extension PCR. sasBF42A was inserted into pMINIMAD2 vector using 
EcoRI and SalI sites. pMINIMAD2 sasBF42A vector was transformed into B. subtilis 168 trpC2 
using a standard transformation protocol. Transformants were selected for erythromycin resistance 
at 45 ºC overnight and grown for 8 hours at room temperature in LB in liquid culture.  Cultures 
were diluted 1:10 in LB and grown overnight. Cultures plated for single colonies and grown 
overnight at 45 ºC. Single colonies were checked for erythromycin sensitivity and sensitive clones 
were checked for sasBF42A allele by Sanger sequencing of sasB amplified genomic region. 
2.8 Y308A RelA strain construction 
relAY308A strain was generated using integration of a pMINIMAD2 derivative (pMINIMAD2 
relAY308A). Briefly, relA was amplified and the Y308A mutation was introduced using overlap 
extension PCR. relAY308A was inserted into pMINIMAD2 vector using EcoRI and BamHI sites. 
pMINIMAD2 relAY308A vector was transformed into B. subtilis 168 trpC2 using a standard 
transformation protocol. Transformants were selected for erythromycin resistance at 45 ºC 
overnight and grown for 8 hours at room temperature in LB in liquid culture. Cultures were diluted 
1:10 in LB and grown overnight. Cultures plated for single colonies and grown overnight at 45 ºC. 
Single colonies were checked for erythromycin sensitivity and sensitive clones were checked for 
relAY308A allele by Sanger sequencing of relA amplified genomic region. 
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2.9 SasB/SasA purification  
Wildtype and F42A SasB and wildtype SasA proteins were expressed and purified essentially 
as described (85). Wildtype sasB and sasA were amplified from B. subtilis 168 trpC2. The F42A 
mutation was introduced using overlap extension PCR. WT and sasBF42A PCR products and WT 
were inserted into pETPHOS expression vector using EcoRI and BamHI sites. pETPHOS WT 
sasB and pETPHOS sasBF42A were transformed into E.coli BL21 and proteins were induced with 
1 mM IPTG for 2 hours at OD600 ~0.5. Cells were harvested at 4 ºC and lysed using a Fastprep 
(MP biomedicals) in 50 mM Tris (pH 8.0), 250 mM NaCl, 5 mM MgCl2, 2 mM BME, 0.2 mM 
PMSF, and 10mM imidazole. Lysates were clarified and bound to a Ni-NTA column (Quiagen) 
for 1 hour. Columns were washed using 20 mM imidazole. Protein was eluted using 500 mM 
imidazole, dialyzed into 20mM Tris, 500 mM NaCl, 5mM MgCl2, 2 mM BME, and 10% glycerol 
and stored at -20 ºC 
2.10 NahA purification  
NahA protein was purified in a similar way to SasB and SasA except that NahA was induced 
for 1 hour at 30 ºC and NahA expressing cells (JDE3138) were lysed, washed, and eluted in 250 
mM NaCl instead of 500 mM.   
2.11 pGpp synthesis 
pGpp was synthesized in vitro by purified NahA enzyme as described (87). Briefly, 10 nM purified 
B. subtilis NahA was incubated with 30 nM pppGpp (Trilink Biotechnologies) in 40 mM Tris-HCl 
(pH 7.5), 100 mM NaCl, 10 mM MgCl2 at 37 ºC for 1 hour. Reactions were monitored for 
conversion of pppGpp to pGpp using thin layer chromatography on PEI-cellulose plates in 1.5 M 
KH2PO (pH 3.6). Nucleotides were visualized using short wave UV light. NahA enzyme was 
precipitated using ice cold acetone and nucleotides were stored at -20 ºC. 
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2.12 SasB activity assay  
SasB activity was assayed by measuring amount of ppGpp generated as described (99). Briefly, 
0.8 mM purified B. subtilis WT or F42A SasB enzyme was incubated with 0.5 mCi of [g-32P]- 
ATP (PerkinElmer) and 50 mM GDP in 20 mM Tris (pH 7.5), 500 mM NaCl, 5 mM MgCl2, 2mM 
BME. SasB was allosterically activated using 12.5 mM pppGpp (Trilink Biotechnologies) and 
pGpp was added to reactions as noted in figures. Reactions were performed in a total volume of 
10 mL, and each reaction was incubated at 37 ºC for 1 min. Each reaction was stopped using 5 mL 
of ice cold acetone. Conversion of ATP to ppGpp was visualized using thin layer chromatography 
on PEI-cellulose plates in 1.5 M KH2PO4 (pH 3.6). Plates were dried completely at RT and exposed 
for 5 min on a phosphor storage screen and visualized (GE Typhoon). ATP and ppGpp spot 
intensities were quantified using ImageJ. 
2.13 Single round transcription termination assays 
Single round transcription termination assays were performed essentially as described in 
(100). Briefly, templates for single round transcription were dsDNA constructs designed to include 
the D. hafniense ilvE riboswitch starting at the predicted natural transcription site and extending 
28 nucleotides beyond the terminator stem. The promoter used to enable transcription is from the 
B. subtilis lysC gene (compatible with the E. coli RNAP). Templates were purchased as dsDNAs 
(IDT) and were amplified using PCR reactions Since ppGpp is known to inhibit the E. coli RNA 
polymerase initiation, the holoenzyme was first assembles into a stalled, stable ternary complex 
befre ppGpp was added with the elongation mixture. 2 pmol of gel purified PCR products were 
added to transcription initiation mixtures (20 mM Tris·HCl (pH 7.5 at 23 °C), 75 mM KCl, 5 mM 
MgCl2, 1 mM DTT, 10 μg mL−1 BSA, 130 μM ApA dinucleotide, 1% glycerol, 0.04 U μL−1 E. 
coli RNA polymerase holoenzyme, 2.5 μM GTP, 2.5 μM 32 ATP, and 1 μM UTP. 1 μCi [a-32P]-
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UTP was added to 8 uL reactions and transcription mixtures were incubated at 37 °C for 10 minutes 
which leads to a stalled polymerase complex at the first cytidine nucleotide for each transcript. 1 
uL of a 10X elongation buffer (20mM Tris·HCl (pH 7.5 at 23 °C), 75 mM KCl, 5 mM MgCl2, 1 
mM DTT, 2 mg mL−1 heparin, 1.5 mM ATP, 1.5 mM GTP, 1.5 mM CTP, and 250 μM UTP) was 
then added to each 8 uL reaction. Each reaction also had 1 uL of a 10X solution of each ligand 
(ppGpp or pGpp). Reactions were incubated at 37 °C for an additional 60 minutes.   
Transcription products were run on 10% PAGE gel and exposed onto a phosphor screen and 
visualized (GE Typhoon). Full length (FL) fraction were calculated using the formula 
(FL)/(FL+T).   
2.14 E. coli RelA purification  
Purified E. coli RelA N-terminal mutant protein (amino acids 1-455) was used to generate 
radio-labelled (pp)pGpp. RelA N-terminal mutant protein was amplified from E. coli MG1655 
strain and inserted into pETPHOS expression vector using NdeI and BamHI sites. pETPHOS relA 
was transformed into E.coli BL21 and proteins were induced with 1 mM IPTG for 1 hours at OD600 
~0.5. Cells were harvested at 4 ºC and lysed using a Fastprep (MP biomedicals) in 50 mM HEPES 
(pH 7.5), 1M KCl, 1mM MgOAC, 4 mM BME, 0.2 mM PMSF, and 10mM imidazole. Lysates 
were clarified and bound to a Ni-NTA column (Quiagen) for 1 hour. Columns were washed using 
20 mM imidazole. Protein was eluted using 250 mM imidazole, dialyzed into 5mM HEPES-KOH, 
1M KCl, 10mM MgOAC, 5 mM BME, and 10% glycerol and stored at -20 ºC.   
2.15 Radio-labelled (pp)pGpp synthesis 
Purified E. coli RelA N-terminal mutant protein (amino acids 1-455) was incubated overnight 
at 30oC with [a-32P]- GTP (PerkinElmer) in 50 mM Tris (pH 8), 15 mM MgOAc, 60 mM KOAc, 
30 mM NH4OAc, 0.2 mM EDTA, and 0.5 mM PMSF. Reactions were supplemented with 8 mM 
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cold ATP. Conversion of GTP to (pp)pGpp (>90%) was monitored by thin layer chromatography 
on PEI-cellulose plates in 1.5 M KH2PO4 (pH 3.6).  
2.16 B. subtilis EF-G purification 
Wildtype B. subtilis EF-G protein was expressed and purified essentially as described in (101). 
Wildtype fusA was amplified from B. subtilis 168 trpC2. fusA PCR product and was inserted into 
pETPHOS expression vector using NdeI and BamHI sites. pETPHOS fusA and was transformed 
into E.coli BL21 and protein expression induced with 1 mM IPTG for overnight at OD600 ~0.5 at 
30 °C. Cells were harvested at 4 ºC and lysed using a Fastprep (MP biomedicals) in 20 mM Tris 
(pH 8.0), 300 mM NaCl, 2 mM BME, 0.2 mM PMSF, and 10mM imidazole. Lysates were clarified 
and bound to a Ni-NTA column (Quiagen) for 1 hour. Columns were washed using 30 mM 
imidazole. Protein was eluted using 250 mM imidazole and 500 mM NaCl, dialyzed into 20mM 
Tris, 100 mM KCl, 20mM MgOAC, 10 mM BME, and 10% glycerol and stored at -20 ºC 
2.17 B. subtilis IF2 purification 
Wildtype and G226A H230A B. subtilis IF2 proteins were expressed and purified essentially 
as described (101). Wildtype infB was amplified from B. subtilis 168 trpC2. The G226A H230A 
mutation was introduced using overlap extension PCR. WT and infBG226AH230A PCR products were 
inserted into pETPHOS expression vector using NdeI and BamHI sites. pETPHOS WT infB and 
pETPHOS infBG226AH230A were transformed into E.coli BL21 and proteins expression induced with 
1 mM IPTG for 4 hours at OD600 ~0.5 at 37 °C. Cells were harvested at 4 ºC and lysed using a 
Fastprep (MP biomedicals) in 20 mM Tris (pH 8.0), 300 mM NaCl, 2 mM BME, 0.2 mM PMSF, 
and 10mM imidazole. Lysates were clarified and bound to a Ni-NTA column (Quiagen) for 1 hour. 
Columns were washed using 30 mM imidazole. Protein was eluted using 250 mM imidazole and 
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500 mM NaCl, dialyzed into 20mM Tris, 100 mM KCl, 20mM MgOAC, 10 mM BME, and 10% 
glycerol and stored at -20 ºC 
2.18 Luminescence growth curves 
Cultures were grown in LB from single colonies grown overnight at 37 ºC on LB plates. 
Cultures in exponential phase (OD600 ~ 0.5-1.0) were diluted to OD600 = 0.1 in 150 µL LB 
containing 4.7 mM D-luciferin (Goldbio) and grown in a 96-well flat bottom white sided plates 
(Greiner Bio-One) plates in triplicate. OD600 and luminescence measurements were made every 5 
min using a Tecan Infinite m200 plate reader and media only wells were used to subtract 
background. 
2.19 RNA quantification  
RNA was quantified from cultures grown in LB as above. At given time points 14 mL of the 
cultures were pelleted at 8 K RCF for 10 minutes at room temperature and frozen at -80 ºC. Pellets 
were re-suspended in TRIzol (Invitrogen) to match based on OD600. ~ 5 OD600 units of all cultures 
were lysed using a FastPrep 24 5G (MP Biomedicals). Lysates were spun down at 20 K RCF for 
20 min and RNA was extracted using the Direct-Zol RNA miniprep kit (Zymo Research). RNA 
samples were DNAse I treated following manufactures protocol (NEB) and 1 µg of RNA was used 
to generate cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). cDNAs were diluted 1:200 and used as templates for qPCR. qPCRs were preformed 
using SYBR green. Primers were design using the PrimeQuest Tool (IDT). No cDNA and no RT 
controls were used to ensure signal was specific to desired RNAs.   
2.20 in vitro translation  
Translation assays used the PURExpress system (NEB) following the manufacture’s protocol 
and a plasmid encoding a CotE-FLAG fusion protein as template DNA (65). ppGpp (TriLink 
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Biotechnologies) at the specified concentrations was added to translation reactions. Reactions were 
run for 20 min each at 37 ºC and stopped by adding 2X SDS loading buffer. Synthesized proteins 
were separated by SDS-PAGE, transferred to PVDF membranes and visualized by probing with 
an anti-FLAG HRP antibody (Sigma). Mutant IF2 was assayed using a ∆IF123 PURExpress kit 
(NEB) supplemented with equal concentrations of purified E. coli IF1 and IF3. Reactions were run 
essentially as above but 0.47 µM of either WT or mutant B. subtilis IF2 was added to each reaction 
as the sole source of IF2. WT and mutant IF2s were purified as described (101). Band intensities 
were analyzed using ImageJ. 
2.21 DRaCALA binding assay 
Radiolabeled (pp)pGpp was generated essentially as described (92). Briefly, purified E. coli 
RelA N-terminal mutant protein (amino acids 1-455) was incubated overnight at 30ºC with [a-
32P]- GTP (PerkinElmer) in 50 mM Tris (pH 8), 15 mM MgOAc, 60 mM KOAc, 30 mM NH4OAc, 
0.2 mM EDTA, and 0.5 mM PMSF. Reactions were supplemented with 8 mM cold ATP. 
Conversion of GTP to (pp)pGpp (>90%) was monitored by thin layer chromatography on PEI-
cellulose plates in 1.5 M KH2PO4 (pH 3.6). DRaCALA binding assays were carried out essentially 
as described (92, 102). 6 µM protein was incubated with 55.5 nM [a-32P]-labeled (pp)pGpp in 40 
mM Tris (pH 8), 100 mM NaCl, 10 mM MgCl2, and 2mM PMSF. Reactions were incubated for 5 
min at RT and 2.5 µL of each reaction was spotted onto nitrocellulose membranes and dried 
completely at RT. Spots were exposed for 30 min on a phosphor storage screen and visualized (GE 
Typhoon). Inner and outer ring intensities were quantified using ImageJ. Reactions where protein 
was not added were used to subtract background.  
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2.22 smFRET experiments 
All of the E. coli components for assembling 30S ICs, including 30S ribosomal subunits, 5’-
biotinylated mRNA, Cyanine (Cy) 3-labeled fMet-tRNAfMet (labeled with maleimide-derivatized 
Cy3 at the naturally occurring 4-thiouridine at residue position 8), IF1, and Cy5-labeled IF2 
(labeled with maleimide-derivatized Cy5 at an engineered cysteine at residue position 810) were 
prepared as previously described (103). 30S ICs lacking IF2 and IF3 were assembled by combining 
0.6 μM 30S subunits, 1.8 μM 5’-biotinylated mRNA, 0.8 μM Cy3-labeled fMet-tRNAfMet, and 0.9 
μM IF1 in Tris-Polymix Buffer (50 mM Tris-OAc (pHRT = 7.5), 100 mM KCl, 5 mM NH4OAc, 5 
mM Mg(OAc)2, 0.1 mM EDTA, 5 mM putrescine-HCl, 1 mM spermidine-free base, and 6 mM β-
mercaptoethanol). The reaction was incubated at 37 °C for 10 minutes then on ice for an additional 
5 minutes. Small aliquots of 30S ICs were flash-frozen in liquid nitrogen and stored at -80 °C.  
To conduct smFRET experiments, 30S ICs assembled were first diluted to a final concentration 
of 75 pM in the presence of 2 uM IF1, 25 nM Cy5-labeled IF2, and 1 mM GTP or ppGpp. 30S ICs 
were then tethered to the polyethylene glycol (PEG)/biotin-PEG-derivatized surface of a 
microfluidic observation flowcell using a biotin-streptavidin-biotin between the 5’-biotinylated 
mRNA and the biotin-PEG. Untethered 30S ICs were flushed from the flowcell, and tethered 30S 
ICs were buffer exchanged, by washing the flowcell with Imaging Buffer (Tris-Polymix Buffer 
with an oxygen scavenging system composed of 2.5 mM 3,4-dihydroxybenzoic acid (PCA) and 
250 mM protocatechuate 3,4-dioxygenase (PCD) and a triplet-state quencher cocktail composed 
of 8.4 mM 1,3,5,7-cyclooctatetraene (COT) and 8.7 mM 3-nitrobenzyl alcohol (NBA)) 
supplemented with 2 uM IF1, 25 nM Cy5-labeled IF2, and 1 mM GTP or ppGpp in order to enable 
rebinding of these components to 30SICs from which they might dissociates during the course of 
imaging. Finally, 30S ICs were imaged at single-molecule resolution and at a 0.1 sec per frame 
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acquisition time using a laboratory-built, prism-based total internal reflection fluorescence (TIRF) 
microscope as previously described (103). A previously described approach (104) was used to 
identify fluorophores and classify them into ‘fluorophore’ or ‘background’ classes; align the Cy3 
and Cy5 imaging channels; fit individual Cy3 and Cy5 fluorophore to 2D Gaussians and estimate 
and, in the case of Cy5, bleedthrough correct the Cy3 and Cy5 fluorescence emission intensity 
versus time trajectories; and generate the EFRET versus time trajectories. Only those trajectories 
exhibiting a signal-to-background (SBR) of 3.5:1 or greater as well as single-step photobleaching 
of Cy3 within the observation time were selected for further analyses.  
In order to estimate the rate constants for the association of IF2 with the 30S IC (ka) and for 
the dissociation of IF2 from the 30S IC (kd) we began by estimating a ‘consensus’ hidden Markov 
model (HMM) of the EFRET versus time trajectories using a slight extension of the variational Bayes 
approach we introduced in the vbFRET algorithm (105) Briefly, instead of using a likelihood 
function for each EFRET versus time trajectory, we used a single likelihood function that 
simultaneously includes all of the EFRET versus time trajectories in a dataset to arrive at a log-
likelihood function given by 
 
ln	(ℒ) = 	 ( ln	(ℒ!)
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where ℒ! is the variational approximation of the likelihood function for a single trajectory. A 
further development of this approach in a hierarchical context underlies the hFRET algorithm that 
we have recently reported(106). Using this consensus HMM approach, we estimated HMMs for 
1-6 states and performed model selection using the highest evidence lower bound (ELBO) as 
described in Bronson et al., 2009. In all cases, the 2-state HMM yielded the highest ELBO. The 




diagonal elements correspond to the number of times a transition takes place between the IF2-free 
and the IF2-bound states of the 30S IC and the on-diagonal elements correspond to the number of 
times a transition does not take place. The 2 rows of this matrix parameterize Dirichlet distributions 
and, for each Dirichlet distribution, we calculated the lower bounds (2.5 %) and upper bounds 
(97.5 %) of the transition probability using the inverse cumulative distribution function of the 
corresponding Dirichlet distribution. These transition probabilities (p) were used to calculate rate 





where t is the time between successive data points (i.e., the acquisition time) (t = 0.1 sec). Finally, 





where k’a is the pseudo-first-order association rate constant calculated using Eq. 2 and [IF2] is the 
concentration of IF2, and we calculated kd directly from Eq 2. The equilibrium dissociation 
constant for IF2 binding to the 30S IS (Kd) was obtained by summing the columns of the 2 x 2 
transition matrix to obtain the total number of data points in which the 30S IC was either in the 
IF2-free state or the IF2-bound state. These sums can then be used to parameterize a Dirichlet 
distribution describing the fraction of 30S ICs in the IF2-bound state (fb). The lower bounds and 
upper bounds of fb were calculated using the inverse cumulative distribution function of this 
Dirichlet distribution, as described above, and the Kd was calculated using the equation Kd / [IF2] 




2.23 G226A H230A IF2 strain construction 
infBG226 H230A strain was generated using integration of pMINIMAD2 derivatives 
(pMINIMAD2 infBG226 H230A). Briefly, infB was amplified excluding start and stop codons and 
G226A H230A mutation was introduced using overlap extension PCR. infBG226 H230A was inserted 
into pMINIMAD2 vector using EcoRI and SalI sites. pMINIMAD2 infBG226 H230A vector was 
transformed into B. subtilis 168 trpC2 using a standard transformation protocol. Transformants 
were selected for erythromycin resistance at 45 ºC overnight and grown for 8 hours at room 
temperature in LB in liquid culture. Cultures were diluted 1:10 in LB and grown overnight. 
Cultures plated for single colonies and grown overnight at 45 ºC. Single colonies were checked 
for erythromycin sensitivity and sensitive clones were checked for infBG226 H230A allele by Sanger 





3 Protein synthesis is downregulated in a (pp)pGpp dependent manner during entry into 
stationary phase 
3.1  Protein synthesis decreases heterogeneously during entry into stationary phase 
In the nutrient-rich medium LB, B. subtilis grows exponentially until a stereotypic cell density, 
presumably dictated by nutrient availability. After this point, growth occurs non-exponentially in 
the transition phase, culminating in the non-proliferative state of stationary phase (Figure 3.1). I 
first wanted to understand how the dynamics of growth compared with energy-intensive processes 
required during exponential phase. I therefore investigated changes in protein synthesis, the most 
energy-intensive process during active growth, during the transition from exponential to stationary 
phase. I measured protein synthesis by measuring incorporation of the puromycin analog O‐
propargyl‐puromycin (OPP) that can be visualized and quantified in single cells following addition 
of a fluorophore using click chemistry (107). Incorporation of OPP results in the accumulation of 
fluorescently tagged nascent polypeptide chains that directly reflect the rate of translation (107) 
(Figure 3.2A). Importantly, OPP incorporation enables the measurement of protein synthesis 
under conditions where amino acids are not specifically limiting as is required during 35S-Met 
incorporation. OPP itself does not inhibit protein synthesis under the conditions I used (OPP 
concentration used to label cells is ~3X lower than the IC50 of puromycin) because incorporation 
of OPP continues to increase even after cells have been exposed to it for 10 minutes (Figure 3.2B). 
OPP incorporation is sensitive to an inhibitor of protein synthesis (chloramphenicol), consistent 
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with it being an appropriate measure of protein synthesis (Figure 3.2B).
 
Figure 3.1 Growth of wildtype B. subtilis. In the nutrient rich medium LB, B. subtilis grows 
exponentially until a stereotypical cell density. After this cell density is reached, growth occurs 
more slowly during a period called transition phase. The cells then enter into stationary phase 
where the population of cells stop growing. Black dashed lines represent the time points where 




















Figure 3.2 OPP labeling of fluorescently tagged nascent polypeptide chains. (A) Schematic 
description of OPP labeling as a measure of protein synthesis. OPP is incorporated into newly 
synthesized polypeptide chains. The alkyne modification on OPP allows the tagged polypeptide to 
be linked to an azide linked fluorescent dye via click chemistry resulting in fluorescent tagging of 
nascent polypeptide chains. (B) OPP does not arrest protein synthesis but is sensitive to inhibition 
by chloramphenicol (Cm). The effect of OPP addition on protein synthesis was tested during 
exponential phase. OPP was added to exponentially growing cultures of WT B. subtilis and total 
fluorescence was measured at 10 minutes and 20 minutes post OPP addition. Increased 
fluorescence was detected 20 minutes after addition compared to 10 minutes after addition 
indicating continued protein synthesis in the presence of OPP. Chloramphenicol was added to a 
separate culture in combination with OPP. Decreased fluorescence indicates that OPP is sensitive 




















I labeled B. subtilis cultures with OPP at a series of time points (Figure 3.1; dashed black 
lines). I designated these time points as: exponential (120 minutes of growth), early transition (400 
minutes of growth), late transition (750 minutes of growth), and stationary (1200 minutes of 
growth). These time points will be used throughout the remainder of this thesis. As expected, cells 
exhibited a progressive decrease in OPP incorporation soon after departure from exponential 
growth (early transition) that continued as the cells grew slowly in late transition phase (Figure 
3.3A). This trend is apparent in the average cellular fluorescence at these time points as well as in 
stationary phase (Figure 3.3A). However, at the late transition time point, the population displayed 
a noticeable heterogeneity. I used ImageJ to analyze microscope images and quantify protein 
synthesis in single cells. Approximately 1500 cells per time point were binned based on their 
fluorescence to generate a population distribution of OPP incorporation (Figure 3.3B). Looking 
at representative population distributions, it became clear that a substantial fraction of cells in the 
entire population exhibited little fluorescent signal (Figure 3.3B “Late transition phase”). This 
indicates an absence of protein synthesis, resulting in a population whose distribution of protein 
synthesis activity is approximately bimodal at the single cell level (Figure 3.3B “Late transition 
phase”). Since some cells in the late transition phase culture exhibited a near total inhibition of 
protein synthesis while others were able to maintain a level of protein synthesis similar to cells in 
the exponential phase (Figure 3.3B), an absence of the nutrients in the extracellular milieu is likely 
not the cause of the inhibition of protein synthesis. This heterogeneity, therefore, is consistent with 
the inhibition of protein synthesis being an active process and not simply a passive consequence 




Figure 3.3 Protein synthesis decrease during entry into stationary phase. Wildtype B. subtilis 
cells were labeled with OPP at different time points throughout growth. (A) Representative 
pictures of wildtype B. subtilis labelled with OPP at different time points. (B) Distributions of 


































































































































I quantified this heterogeneity using a cutoff that specifies the population of cells with low 
protein synthesis activity. I defined the threshold of this cutoff as the magnitude of OPP labeling 
of a stationary phase wildtype B. subtilis culture that captures 95% of the entire population. I 
determined this threshold (850 RFU) using distributions of three separate cultures of wildtype 
stationary phase cells (Figure 3.4A). I then used this threshold to quantify the percent of the 
population with low rates of protein synthesis (“OFF”) (Figure 3.4B). By convention, the 
remainder of the population is defined as “ON.” Using this cutoff, I quantified the percentage of 
OPP “OFF” cells throughout growth (Figure 3.5). During late transition phase, when the 
heterogeneity is most apparent (Figure 3.3), the proportion of cells with low rates of protein 





Figure 3.4 Demonstration of method to quantify OPP “OFF” cells. Threshold for OPP “OFF” 
cells was determined as the fluorescence value (850 a.u.) that is higher than >95% of cells of OPP 
labeled wildtype B. subtilis during stationary phase across three independent experiments. (A) 
Three representative distributions of OPP labeled wildtype B. subtilis. Gray box shows cutoff for 
cells with low rates of protein synthesis (“OFF”). (B) Quantitation of % of population below the 











































































































































Figure 3.5 Quantitation of OPP “OFF” cells throughout growth in wildtype B. subtilis. 
Percent of the population of wildtype B. subtilis below the OPP “OFF” threshold determined in 























3.2 Cell wall sensitive kinase/phosphatase pair is required for down regulation of protein 
synthesis 
The shutoff of protein synthesis in a subpopulation of cells suggests that protein synthesis is 
inhibited in these cells in a manner not directly related to a significant decrease in amino acid 
availability (Figure 3.3). What mechanism could account for this inhibition? One possibility is 
that during the late transition phase, B. subtilis senses a change in different cellular process and 
directly mediates the inhibition of protein synthesis in a subpopulation of cells. I first asked if one 
of the major sensing systems in B. subtilis could mediate this shutoff of protein synthesis. Signaling 
through eSTK signaling systems has previously been shown to regulate protein synthesis during 
the transition between growth and dormant phenotypes in B. subtilis (65). One of these eSTKs is 
the PASTA domain containing membrane-bound protein PrkC, which has been shown to directly 
sense peptidoglycan fragments in the cellular milieu (60, 108). PrkC and its partner phosphatase 
PrpC have also been shown to affect expression of stationary phase specific genes (63, 108). 
Specifically, PrkC and PrpC regulate the phosphorylation of WalR (the response regulator of the 
essential TCS in B. subtilis) on Thr-101(63). This phosphorylation in turn, affects expression of a 
group of stationary phase specific genes (63). One of these genes, sasA, is an interesting candidate 
for mediating the downregulation of protein synthesis because it generates a group of nucleotides 
((pp)pGpp) (Figure 1.2) that have been previously suggested to directly inhibit protein synthesis 
(75, 79). Furthermore, expression of sasA occurs heterogeneously from cell to cell during exit from 
exponential phase, and this heterogeneity is affected by PrkC and PrpC (64). Thus, PrkC/PrpC 
signaling during entry into stationary phase could affect heterogeneity in protein synthesis.    
To test this hypothesis, I compared OPP incorporation of strains lacking either PrkC (Figure 
3.6B) or PrpC (Figure 3.6C) during late transition phase to a wildtype strain (Figure 3.6A). 
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Deletion of PrkC resulted in the loss of cells with low rates of protein synthesis (“OFF”) during 
late transition phase compared to a wildtype strain (Figure 3.6A, B). In contrast, cells with 
comparatively high rates of protein synthesis are less frequent in a strain lacking PrpC as compared 
to a wildtype strain (Figure 3.6A, C). I quantified these effects over three independent experiments 
(Figure 3.6D) and observed significantly fewer “OFF” cells in the DprkC strain and significantly 
more “OFF” cells in the DprpC strain compared to wildtype. These results suggest that sensing 
through PrkC mediates the inhibition of protein synthesis that is observed during late transition 
phase. The opposing effects of PrkC and PrpC on protein synthesis also suggest that the mediator 
of heterogeneity in protein synthesis is a target of PrkC based phosphorylation. As mentioned 
above, WalR phosphorylation is regulated by PrkC and PrpC during stationary phase, and this 
phosphorylation affects stationary phase specific gene expression (63). Based on these data, I 
speculated that PrkC/PrpC based signaling mediated the inhibition of protein synthesis during 






Figure 3.6 Heterogeneity is dependent on signaling via PrkC/PrpC. (A, B, C) Representative 
picture and population distribution of OPP labeled (A) wildtype (B) ∆prkC and (C) ∆prpC strains 
during late transition phase. (D) Quantitation of OPP “OFF” cells over three independent 











































































3.3 (pp)pGpp is required for down regulation of protein synthesis  
As previously mentioned, PrkC/PrpC mediated phosphorylation of WalR affects noise in gene 
expression during the transition from growth to stationary phase (64). Specifically, noise in the 
expression of sasA, a gene previously identified as a (pp)pGppp synthetase in B. subtilis is 
dependent on the phosphorylation status of WalR (63, 64). Expression of sasA is interesting for 
two reasons. Firstly, heterogeneity in sasA expression is differentially affected by deletion of PrkC 
and PrpC (64). Since deletion of either of these signaling proteins also has opposite effects on the 
heterogeneity in protein synthesis, the heterogeneity in sasA expression could be related to the 
heterogeneity in protein synthesis. I will explore this link in detail in Chapter 4 of this thesis.  
Secondly, SasA has been shown to produce a group of molecules that are major regulators of 
energy intensive-processes in bacteria; the guanosine molecules collectively referred to as 
(pp)pGpp (Figure 1.2) (79). (pp)pGpp is an attractive candidate to directly downregulate protein 
synthesis during exit from exponential growth because it downregulates diverse processes in cells 
growing under nutrient limited conditions (109). Furthermore, many bacteria synthesize (pp)pGpp 
when they depart from exponential phase (110, 111). To investigate the possible role of (pp)pGpp, 
I asked if (pp)pGpp is necessary for cells with low rates of protein synthesis during exit from 
growth. To do this, I utilized a strain that lacks (pp)pGpp via a genetic deletion of the three known 
B. subtilis (pp)pGpp synthetases, relA, sasA, and sasB (112, 113), which I will refer to as 
(pp)pGpp0. Under the growth conditions used here, the (pp)pGpp0 strain grows equivalently to the 
parent wildtype strain during exponential phase as well as early and late transition phase, and based 
on OD600 the cells at these time points do not have any significant difference in viability (Figure 
3.7). At approximately 75 minutes after the late transition phase time point, the (pp)pGpp0 strain 
begins to lyse (Figure 3.7). For this reason, I will only examine protein synthesis in this strain 
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only at or before the late transition phase time point. As above, I assayed protein synthesis of the 
(pp)pGpp0 strain by measuring OPP incorporation. Since (pp)pGpp concentration is low in 
exponential phase (87), as expected, OPP incorporation of this strain is indistinguishable from the 
parent (Figure 3.8A, B “Exponential”). In contrast, early in transition phase, the distribution of 
OPP incorporation by (pp)pGpp0 cells is higher as compared to the wildtype parent (Figure 3.8A, 
B “Early Transition”). This trend continues, and in late transition phase, significantly fewer cells 
in the (pp)pGpp0 strain (blue) have decreased their protein synthesis as compared to the wildtype 
parent (gray) (Figure 3.8A, B “Late Transition phase”). The percent of the population with 
comparatively low rates of protein synthesis “OFF” is significantly different between these two 
strains during the late transition phase time point (Figure 3.8 C).   
The results above indicate that (pp)pGpp is required to inhibit protein synthesis in a 
subpopulation of cells during entry into stationary phase because the population with 
comparatively lower levels of OPP incorporation (“OFF”) is absent in a strain that lacks (pp)pGpp. 
To confirm that the difference observed between the wildtype and the (pp)pGpp0 strains was not 
due to any differences in the OPP reporter that were not directly due to differences in protein 
synthesis activity, I used methionine incorporation, a more conventional method of measuring 
protein synthesis activity. The fluorescently tagged methionine analog (HPG) has been previously 
used as a probe for protein synthesis activity in bacteria (114). Although incorporation of this 
analog is not efficient in media containing methionine (the (pp)pGpp0 strain requires methionine 
to grow (115)), the (pp)pGpp0 strain incorporated comparatively more HPG during late transition 
phase, consistent with a higher rate of protein synthesis (Figure 3.9).   
For the remainder of this thesis, I will explore the mechanistic basis of this phenomenon. 
Chapter 4 will investigate how heterogeneity in protein synthesis is derived via (pp)pGpp and the 
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synthetases responsible for generating these nucleotides. Chapter 5 will investigate how protein 




Figure 3.7 Growth curve of B. subtilis lacking (pp)pGpp0. Growth in a strain of B. subtilis 
lacking (pp)pGpp (blue) is comparable to a wildtype (gray) strain during exponential and transition 



















Figure 3.8 (pp)pGpp is required for inhibition of protein synthesis during late transition 
phase (A) Representative pictures of WT and (pp)pGpp0 strains labelled with OPP at different 
time points. (B) Distributions of mean-cell fluorescence of WT (gray) and (pp)pGpp0 (blue) cells. 
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Figure 3.9 (pp)pGpp0 effect is also observable using HPG labeling. The effect of (pp)pGpp on 
protein synthesis was confirmed using a fluorescently taggable methionine analog. Rates of protein 





















4 Cross-talk between nucleotide second messengers drives heterogeneity in protein 
synthesis 
4.1 SasA and SasB have opposing effects on heterogeneity  
Cellular heterogeneity in protein synthesis as B. subtilis cultures exit rapid growth is 
dependent on the presence of the phosphorylated guanosine nucleotides (pp)pGpp (Figure 3.8). 
B. subtilis contains three proteins (RelA, SasA, SasB) that generate the nucleotides (pp)pGpp (82, 
112). Whereas RelA is ribosome-associated and requires a starved ribosome to synthesize pppGpp, 
SasA and SasB are believed to be transcriptionally activated (79, 80). Furthermore, they lack the 
domains present in RelA that are required for ribosome association and sensing of A-site 
uncharged tRNAs (80, 81). Additionally, expression of SasA and SasB increases during exit from 
rapid growth (79). I wanted to investigate the mechanistic basis of heterogeneity in protein 
synthesis and decided to assess single cell protein synthesis using (OPP) incorporation in strains 
carrying inactivating mutations in either of the two B. subtilis SAS proteins because their 
expression increases during exit from growth when heterogeneity is observable.    
When I analyzed a representative population distribution of a strain lacking SasB (∆sasB), 
I observed that this strain contained fewer “OFF” cells as compared to the wildtype strain (Figure 
4.1 A, B). In contrast, a strain lacking SasA (∆sasA) does not contain the substantial fraction of 
“ON” cells seen in the wildtype parent strain, and most cells in the population are “OFF” (Figure 
4.1 A, C). These differences are quantified across three independent experiments in Figure 4.1D. 
These results indicate that while both SasA and SasB are required for the heterogeneity I observed, 




Figure 4.1 SasB and SasA have opposing effects on protein synthesis. (A, B, C) Representative 
picture and population distribution of OPP labeled (A) wildtype, (B) DsasB, and (C) DsasA strains 
during late transition phase. (D) Quantitation of OPP “OFF” cells over three independent 










































































4.2  sasA but not sasB expression is correlated with levels of protein synthesis 
sasA and sasB are believed to be regulated transcriptionally and their expression increases 
post-exponentially (79, 112) when the heterogeneity is observed (Figure 3.3). I therefore asked if 
expression of either sasA or sasB is correlated with protein synthesis using reporters consisting of 
transcriptional fusions of the sasA or the sasB promoters to YFP (PsasA-yfp or PsasB-yfp) integrated 
at a neutral chromosomal site. As previously observed (79), both sasA and sasB expression 
increased during the exit from exponential growth (Figure 4.2 A, B). I examined the relationship 
between promoter activity and protein synthesis by measuring both YFP expression and OPP 
incorporation in single cells. Cells with higher sasA expression (PsasA-yfp) are more likely to have 
higher levels of protein synthesis than cells with lower sasA expression (Figure 4.2 D). If the 
population is divided into quartiles of sasA expression, the average OPP incorporation in the top 
two quartiles as compared to the bottom quartile is significantly higher (Figure 4.2 D). In 
comparison, there was no significant difference in OPP incorporation between any quartiles of 
sasB expression (Figure 4.2 C). Thus, differences in sasA, but not sasB, expression are associated 




Figure 4.2. Relationship between sasA or sasB expression and OPP incorporation. (A, B) 
Representative population distribution of B. subtilis carrying a transcriptional reporter of (A) 
PsasB-yfp or (B) PsasA-yfp during exponential and late transition phase. (C, D) Average OPP 
incorporation of each quartile of (C) PsasB-yfp expression or (D) PsasA-yfp expression from 
lowest to highest. Statistical analysis (one tailed t-test) showed no significance (p > 0.05) in OPP 
incorporation between any PsasB-YFP, and significantly higher OPP incorporation between 
quartiles 1 and 3 and quartiles 1 and 4 of PsasA-yfp expression. (means ± SDs). n.s. p > 0.05, *p 





































































4.3 SasB allosteric activation is necessary for heterogeneity 
If changes in sasB transcription are not associated with differences in protein synthesis 
(Figure 4.2C), but SasB is necessary for the heterogeneity of protein synthesis (Figure 4.1B), 
what mechanism is responsible for differential SasB activity in single cells? B. subtilis SasB is 
subject to allosteric activation by pppGpp, the main product of the B. subtilis RSH homolog RelA 
(85). Phe-42 is a key residue in this activation, and a SasB mutant protein carrying an F42A 
substitution is no longer allosterically activated by pppGpp (85). I investigated the importance of 
this allosteric activation for the heterogeneity of protein synthesis activity using a strain expressing 
an F42A SasB mutant protein. Heterogeneity of this strain is significantly attenuated compared to 
the WT strain, demonstrating the importance of the allosteric activation of SasB by pppGpp for 
the bimodality of protein synthesis activity (Figure 4.3 A, B, D). 
This result suggests that the enzyme responsible for pppGpp synthesis would also affect 
the heterogeneity. RelA is the primary source of pppGpp in B. subtilis (116), so the loss of relA 
would be predicted to affect SasB activity. I, therefore, generated a strain expressing a RelA mutant 
protein (RelAY308A) carrying a single amino acid change at a conserved residue essential for 
synthase but not hydrolysis activity (117, 118) since RelA hydrolytic activity is essential in a strain 
that retains functional sasA and sasB genes (113). Labeling of this strain with OPP in late transition 
phase revealed that it largely lacked the “OFF” population (Figure 4.3 C, D), demonstrating that 




Figure 4.3 Allosteric activation of SasB is required for cells with low protein synthesis. (A, 
B, C) Representative picture and population distribution of OPP labeled (A) wildtype, (B) 
sasBF42A, and (C) relAY308A strains during late transition phase. (D) Quantitation of OPP “OFF” 
cells over three independent experiments for A-C (means ± SDs). n.s. p > 0.05, *p < 0.05, **p < 











































































4.4 SasB allosteric activation is inhibited by pGpp 
A strain lacking SasA (∆sasA) contains more “OFF” cells as compared to the wildtype 
parent (Figure 4.1 C). The presence of this sub-population of cells (“OFF”) depends on a SasB 
protein that can be allosterically activated (Figure 4.3 B). Integrating these two observations, I 
hypothesized that the product of SasA (pGpp) inhibits the allosteric activation of SasB by pppGpp. 
The similarity of these molecules suggests that they could have an antagonistic interaction since 
they are likely capable of binding to the same site on SasB, but their differing phosphorylation 
states could affect their ability to allosterically activate SasB. 
I tested this model by assaying in vitro whether pGpp inhibits the allosteric activation of 
SasB. First, I confirmed, as previously reported, that SasB generates more ppGpp when reactions 
are supplemented with pppGpp (85) and observed a ~2 fold increase in ppGpp production when 
SasB was incubated with pppGpp (Figure 4.4 A). Using pGpp synthesized in vitro by the newly 
identified (pp)pGpp hydrolase NahA (87), I observed that pGpp attenuates the allosteric activation 
of SasB in a dose dependent manner (Figure 4.4 A). Since even the highest concentration of pGpp 
did not decrease production of ppGpp relative to that generated by SasB without the addition of 
pppGpp (Figure 4.4 A), the inhibition is likely specific to the allosteric activation. I tested this 
directly by assaying the effect of pGpp on SasB activity in the absence of its allosteric activator 
(pppGpp). Addition of pGpp did not significantly affect SasB activity within the range of pGpp 
concentrations I used previously (Figure 4.4 C). I also confirmed the specificity by assaying a 
SasB F42A mutant protein (SasBF42A) that is insensitive to allosteric activation by pppGpp (85). 
As previously reported, SasBF42A had similar activity to a non-allosterically activated WT SasB in 
the presence of pppGpp (Figure 4.4 B). However, in contrast with wildtype SasB, pGpp did not 




Figure 4.4 pGpp inhibits allosteric activation of SasB by pppGpp 
(A) Representative TLC of nucleotides present following incubation of wildtype SasB with [a-
32P]-ATP and GDP in the presence or absence of pppGpp and increasing concentrations of pGpp 
(top). Quantitation of the ratio of ppGpp present in each lane in TLC. Ratio of ppGpp calculated 
using the formula, ppGpp/ATP + ppGpp (bottom) (B) Representative TLC of nucleotides present 
following incubation of SasBF42A with [a-32P]-ATP and GDP in the presence or absence of pppGpp 
and increasing concentrations of pGpp (top). Ratio of ppGpp present in each lane in TLC. As 
determined the formula, ppGpp/ATP + ppGpp (bottom). Statistical analysis (two tailed t-test) 
showed no significance (p > 0.05) between reactions containing SasB whether or not pppGpp and 
pGpp was included. (C) Representative TLC of nucleotides present following incubation of 
wildtype SasB with [a-32P]-ATP and GDP in the absence of pppGpp and increasing concentrations 
of pGpp (top). Ratio of ppGpp present in each lane in TLC. As determined the formula, 
ppGpp/ATP + ppGpp (bottom). Statistical analysis (two tailed t-test) showed no significance (p > 
0.05) between reactions containing SasB whether or not and pGpp was included. (means ± SDs). 












































































































4.5  Cross-talk between nucleotides is not observed on (pp)pGpp RNA sensor 
The allosteric activation of SasB (by pppGpp) is inhibited in the presence of the nucleotide 
generated by SasA (pGpp) (Figure 4.4). These data suggest that, at least in vitro, SasB is able to 
integrate the relative levels of either of these two nucleotides and this results in an either 
allosterically activated SasB (when pppGpp is bound) that produces comparatively high amounts 
of ppGpp or an allosterically inactivated SasB (when pGpp is bound) that produces comparatively 
low amounts of ppGpp. The differential action of these two nucleotides is surprising given that 
they are structurally similar. It does, however, allow for a more fine-tuned response that 
presumably relies on the information communicated through either comparatively low or high 
concentrations of either of these two nucleotides (cell wall metabolism and amino acid 
availability). I wondered if this kind of cross-talk between phosphorylated guanosine nucleotides 
also occurred in a different system. 
Recently, a new class of riboswitches that bind ppGpp has been identified in Firmicutes (100). 
Riboswitches are RNA structures within non-coding sections of certain mRNAs that act as 
regulators of gene expression by directly binding small molecules such as metabolites, coenzymes, 
signaling molecules, or inorganic ion ligands (119). Upon binding their corresponding small 
molecule, the riboswitch folding pattern changes, and this change affects the expression of the 
downstream mRNA (119). Binding of ppGpp to a riboswitch present in the 5’UTR of the ilvE gene 
in Desulfitobacterium hafniense (D. hafniense) was shown to differentially control transcription 
termination (100). Specifically, the P3 helix of this aptamer, which acts as a transcriptional anti-
terminator, is stabilized in the presence of ppGpp so that when ppGpp is bound, more full-length 
transcript is generated (100). I wondered if RNA based ppGpp sensors could also be subjected to 
the crosstalk I observed on SasB. This would not only suggest that this kind of crosstalk between 
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phosphorylated guanosine nucleotides is a conserved mechanism in bacterial physiology but would 
also add an interesting level of regulation on riboswitches because it would allow for the 
integration of multiple signals on one RNA molecule.   
I decided to test if transcriptional termination by the D. hafniense ilvE 5’UTR encoded 
riboswitch, which is anti-terminated in the presence of ppGpp was differentially affected by pGpp. 
To do this, I measured the amount of full-length transcript (FL) and terminated transcript (T) 
present in single turnover in vitro transcription termination assays (100). As previously shown, the 
expression platform, which contains the natural transcription start site and the ppGpp binding 
riboswitch of the D. hafniense ilvE and ends 28 nucleotides beyond the terminator stem, operates 
with the E. coli RNA polymerase and generates a FL transcript and a T transcript in the absence 
of ppGpp (Figure 4.5). When I added ppGpp to these reactions, the amount of FL is significantly 
higher, indicating that ppGpp binding anti-terminated the transcript (Figure 4.5). Next I asked if 
pGpp had a similar or different effect on anti-termination of this transcript. Inclusion of pGpp in 
these reactions similarly increased the amount of FL indicating that pGpp also anti-terminates 
transcription by the D. hafniense ilvE riboswitch (Figure 4.6). These results suggest that, unlike 
SasB, the D. hafniense ilvE riboswitch is not subject to cross-talk between phosphorylated 
guanosine nucleotides because both nucleotides have the same action. At this time however, I 
cannot rule out that this kind of regulation does occur on a different naturally occurring ppGpp 





Figure 4.5 ppGpp and pGpp have similar functions on a ppGpp binding riboswitch. Anti-
termination of the D. hafniense ilvE riboswitch by ppGpp was measured using single turnover in 
vitro transcription termination assays. Termination of the full length (FL) transcript occurs in the 
absence of any added nucleotide (gray) and a terminated (T) transcript is observable. In the 
presence of 100 uM ppGpp (navy) the terminated transcript is missing and the fraction of FL 
transcript generated increases. Similarly to the action of ppGpp, pGpp also antiterminates the D. 
hafniense ilvE riboswitch and reactions with 100 uM pGpp (green) have significantly more FL 
than reaction without any nucleotide added. (means ± SDs). n.s. p > 0.05, *p < 0.05, **p < 0.01, 





















4.6 The effect of sasA depends on sasB and relA 
The in vitro biochemical experiments in (Figure 4.4) suggests that the effect of SasA on 
the heterogeneity of protein synthesis is dependent on the activity of SasB. If this is true in vivo, 
then a sasB deletion should be epistatic to a sasA deletion. Consistently, a strain lacking both SasA 
and SasB (DsasA DsasB) exhibits a loss of heterogeneity in comparison to the single sasA deletion 
(Figure 4.6 A, B, D). Thus, the effect of SasA is dependent in vivo on SasB. Finally, since RelA 
activates SasB, a ∆sasA mutation should be epistatic to a relA mutation with respect to protein 
synthesis. A strain expressing RelAY308A and carrying a ∆sasA mutation exhibits a similar loss of 
heterogeneity as compared to relAY308A, demonstrating that the effect of the ∆sasA mutation 
depends on a functional RelA synthetase (Figure 4.6 A, B, D). This result is consistent with the 





Figure 4.6 The effect of sasA depends on sasA and relA. (A, B, C) Representative picture and 
population distribution of OPP labeled (A) DsasA, (B) DsasA DsasB, and (C) DsasA relAY308A 
strains during late transition phase. (D) Quantitation of OPP “OFF” cells over three independent 
















































































5 (pp)pGpp directly regulates translation initiation during entry into quiescence 
5.1 ppGpp is sufficient to inhibit protein synthesis 
The data provided in Chapter 4 indicates that during entry into stationary phase, a network of 
(pp)pGpp synthetases regulate heterogeneity of protein synthesis by regulating the allosteric 
activation of SasB (Figures 4.3). The main activity of SasB in B. subtilis is to generate the tetra-
phosphorylated guanosine nucleotide, ppGpp (79). I also showed that (pp)pGpp is required for the 
down-regulation of protein synthesis in a subpopulation of cells during entry into stationary phase 
(Figure 3.8 “Late transition”). (pp)pGpp has previously been suggested to directly inhibit 
translation by binding to and inhibiting the function of translational GTPases, including IF2 and 
EF-Tu (75, 120). That (pp)pGpp directly inhibits translation and regulates protein synthesis in vivo 
has not been shown, however. These data together address how the heterogeneity is derived and 
suggest that the accumulation of ppGpp in the subpopulation of cells with comparatively low levels 
of protein synthesis directly inhibits translation. The biochemical mechanism by which protein 
synthesis itself is down-regulated is not directly addressed by these data, however. To more closely 
understand if ppGpp directly inhibits protein synthesis, I first asked if ppGpp on its own can inhibit 
protein synthesis in vivo.   
To address this question, I placed the B. subtilis (pp)pGpp synthetase sasB under the control 
of a xylose inducible promoter (Pxyl) in a strain lacking RelA, the bifunctional (pp)pGpp synthetase 
and hydrolase, as well the accessory (pp)pGpp synthetases SasA and SasB. The RelA mutation is 
required for accumulation of ppGpp during sasB expression, presumably because it would 
hydrolyze the ppGpp generated during log phase if it was present (79). The SasA and SasB 
mutations are required to delete RelA because its hydrolytic activity is essential in a strain with 
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SasA and SasB (115). As previously observed (79), induction of sasB in the presence of these 
mutations during exponential phase (T0) results in the accumulation of ppGpp without a noticeable 
decrease in growth during exponential phase (Figure 5.1A). To determine how ppGpp affects 
protein synthesis, I labeled cells with OPP following a 60 minute xylose treatment (T60) (Figure 
5.1A). At 60 minutes following inducer addition (T60), protein synthesis is significantly reduced 
in the induced culture as compared to the un-induced culture as can be seen in representative 
pictures and population distributions of OPP labeling (Figure 5.1 B, C). This effect is quantified 
in Figure 5.1 D over three independent experiments, which show that protein synthesis is 
decreased by 40% in cells expressing sasB for 60 minutes during exponential phase (Figure 5.1 




Figure 5.1 sasB expression is sufficient to inhibit protein synthesis. The effect of ppGpp on 
protein synthesis was tested in vivo using expression of an inducible ppGpp synthase, sasB. (A) 
Growth of a Pxyl-sasB strain in the presence and absence of induction. Induction of sasB occurs 
during logarithmic growth (T0) with 0.05% xylose (xyl). Cells growth is monitored throughout 
exponential phase and labeled with OPP at 60 minutes after xyl addition (T60). (B) Representative 
pictures of OPP-labeled induced and uninduced cultures of a Pxyl-sasB strain 60 min after induction 
(T60). (C) Representative population distributions of OPP-labled induced and uninduced cultures 
of a Pxyl-sasB strain 60 min after induction (T60). (C) Average cellular Fluorescence (RFU) of OPP-
labeled induced and uninduced cultures of a Pxyl-sasB strain 60 min after induction (T60) across 





































































5.2 ppGpp inhibits translation specifically 
Given the potential complications in distinguishing indirect effects of (pp)pGpp on global 
protein synthesis, such as those involving translation of ribosomal proteins, these experiments do 
not assess a direct effect of (pp)pGpp on translation. To directly address this I utilized the 
PURExpress in vitro reconstituted, coupled transcription-translation system (NEB) that utilizes a 
defined mix of purified transcription and E. coli translation components to transcribe and translate 
a specific mRNA (121). This purified system is appropriate to study the effects of ppGpp on 
translation because it utilizes purified components including the T7 RNA polymerase, which has 
been previously shown to be insensitive to ppGpp (122). Addition of ppGpp to PURExpress 
reactions inhibited synthesis of a reporter protein (CotE) in a dose-dependent fashion (Figure 5.2 
A). Concentrations of ppGpp sufficient to significantly inhibit CotE synthesis (~1 mM) are similar 
to those of (pp)pGpp observed during stringent response induction in E. coli (123). qRT-PCR 
analysis demonstrated that ppGpp had no effect on cotE transcription at concentrations where CotE 
synthesis was significantly impaired (Figure 5.2 B), consistent with the known insensitivity of the 
T7 RNA polymerase used in the PURExpress reaction to ppGpp (122). Thus, ppGpp directly 




Figure 5.2 ppGpp directly inhibits translation. (A) Protein synthesis activity is monitored using 
production of CotE-FLAG protein by a PUREexpress reaction (NEB) in the absence or presence 
of ppGpp was assayed via Western blot with α-FLAG. (B) Synthesis of in vitro transcribed cotE 
mRNA was measured by quantifying total mRNA produced in the presence of a concentration 
of ppGpp (1mM) that significantly inhibits protein production. RNA was quantified using RT-












































5.3 IF2 is a target of (pp)pGpp 
Given these observations, I wished to identify the component(s) of the translation machinery 
that is (are) targeted by ppGpp in vivo. The translational GTPases EF-Tu (124), EF-G (125), and 
IF2 (126, 127), as well as the ribosome-associated GTPases including Obg (76, 128), RsgA (92, 
129), RbgA (92, 130), Era (92), and HflX (92, 129), have all been reported to bind ppGpp. 
However, since ppGpp inhibits protein synthesis by the PURExpress system (Figure 5.2 A), which 
contains IF2, EF-Tu, and EF-G, but not the other GTPases, inhibition of one or more of these three 
proteins is likely sufficient to account for the in vivo inhibitory effect of (pp)pGpp on translation.   
I first investigated whether IF2 was a target under my conditions because it has been proposed 
to serve as a “metabolic sensor” of (pp)pGpp (127). I therefore attempted to identify mutations in 
IF2 that would affect (pp)pGpp binding without disrupting GTP binding sufficiently to impair 
normal function. E. coli EF-G and IF2 have a differential affinity for (pp)pGpp (125) and similar 
but not absolutely conserved G domains. So, if I could identify residue(s) that affect this difference, 
this information might allow me to construct a B. subtilis IF2 allele less sensitive to (pp)pGpp. I 
focused on those IF2 residues which display a shift in NMR spectra upon binding of ppGpp as 
compared to GDP (Figure 5.3 B, blue residues) (127) since GDP interacts with multiple residues 
in the G domain of IF2 (131). I aligned the region containing those residues (i.e., the G1 motif) 
with the homologous region in EF-G, which has lower affinity for (pp)pGpp than IF2 (Figure 5.3 
A). I noted that one of the blue residues in IF2, Gly-226, is an alanine residue (Ala-18) in EF-G 
(Figure 5.3 B, red). In addition, the histidine residue (His-230) in IF2 that is adjacent to the two 
blue residues is an alanine (Ala-21) in EF-G (Figure 5.3 B, red). These differences suggested that 
substituting the IF2 residues with the corresponding residues found in EF-G would affect the 
ability of IF2 to bind (pp)pGpp. I therefore used the DRaCALA filter binding assay and observed 
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that the double mutant IF2 (G226A H230A) bound (pp)pGpp significantly less well than the 
wildtype protein (Figure 5.3 C). 
To test the functional consequence of mutating these residues in B. subtilis IF2, I used a 
PURExpress kit that lacks IF2 (DIF2). I first confirmed that the DIF2 kit, which contains purified 
E. coli translation factors, works equivalently whether the added IF2 is derived from E. coli or B. 
subtilis (Figure 5.4 B). When supplied as the sole source of IF2 in this reaction, the double mutant 
B. subtilis IF2 produced an equivalent amount of protein as wild type B. subtilis IF2 (Figure 5.4 
B), demonstrating that the slight reduction in GTP binding (Figure 5.4 A) did not substantially 
affect IF2 function in translation. However, the double mutant B. subtilis IF2 was significantly less 
sensitive to ppGpp inhibition than its wild type counterpart (Figure 5.3 D). Taken together, these 
results indicate that ppGpp binding to IF2 accounts for a substantial portion of the inhibition of 




Figure 5.3 IF2 is a target of ppGpp IF2 was validated in vitro as a direct target of ppGpp using 
IF2 mutations that reduce ppGpp binding. (A) Affinity of B. subtilis EF-G and IF2 for (p)ppGpp 
was compared using the differential radial capillary action of a ligand assay (DRaCALA) (102). 
(means ± SDs). (B) Alignment of G1 domains of B. subtilis IF2 and EF-G. Residues in blue denote 
those most shifted upon binding of ppGpp versus GDP (127). Residues in red are those that differ 
in EF-G and IF2 and were used to engineer a mutant IF2 with reduced affinity for ppGpp (G226A 
H230A). (C) DRaCALA-based comparison of (p)ppGpp affinity for WT and mutant IF2 (means 
± SDs). (D) In vitro sensitivity of WT and mutant IF2 was assessed using the PURExpress system 
(NEB). WT and mutant IF2 were added at equimolar amounts to separate PURExpress reactions 
in the presence of 1mM ppGpp and protein synthesis was monitored by Western blot (means ± 












































































Figure 5.4 G226A H230A IF2 mutant binds GTP less but is not inhibited in function. (A) 
GTP binding and (B) function of G226A H230A IF2 mutant was assayed using DRaCALA assay 



















































5.4 ppGpp fails to allosterically activate IF2 for rapid subunit joining 
Previously, Milón and colleagues demonstrated that ppGpp inhibits IF2’s ability to catalyze 
30S IC assembly and subunit joining (127). To elucidate the structural basis of this inhibition, I 
worked in collaboration with Ruben Gonzalez’s lab in the Chemistry department at Columbia to 
investigate how ppGpp inhibits IF2 function. The Gonzalez lab has previously developed a single 
molecule FRET method to observe structural aspects of IF2 binding to the 30S IC (132) and has 
shown that GTP binding allosterically positions IF2 in a confirmation that mediates rapid 50S 
subunit joining (103). We wished to determine whether and how ppGpp influences the binding of 
E. coli IF2 to the E. coli 30S IC and the conformational dynamics of E. coli 30S IC-bound IF2. 
Briefly, IF2 promotes binding of initiator tRNA (fMet-tRNAfMet) to the 30S subunit and uses its 
domain IV (dIV) to directly contact the N-formyl-methionine and aminoacyl acceptor stem of 
fMet-tRNAfMet, resulting in formation of an IF2-tRNA sub-complex on the intersubunit surface of 
the 30S IC (133). The presence of GTP in the G domain and recognition of fMet-tRNAfMet by dIV 
‘activate’ 30S IC-bound IF2 for rapid subunit joining (134). We previously used an IF2-tRNA 
single-molecule fluorescence resonance energy transfer (smFRET) signal (132), to show that 
activation of IF2 for rapid subunit joining involves a GTP- and fMet-tRNAfMet-dependent 
conformational change of IF2 that results in an increase in the affinity of IF2 for the 30S IC and 
an increase in the rate of subunit joining (103). To understand how ppGpp affected this interaction, 
we began by comparing the affinities of GTP-bound IF2 (IF2(GTP)) and ppGpp-bound IF2 
(IF2(ppGpp)) for the 30S IC. As in our previous studies (103, 132), EFRET versus time trajectories 
recorded for individual 30S ICs fluctuate between a zero FRET state (IF2-free 30S IC) and a non-
zero FRET state (IF2-bound 30S IC) (Figure 5.5, third row). Initial inspection of these trajectories 
and the corresponding surface contour plots of the post-synchronized time evolution of population 
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FRET reveals that, while IF2(GTP) exhibits relatively long-lived and stable binding events on the 
30S IC, IF2(ppGpp) exhibits significantly shorter-lived and unstable binding events (Figure 5.5, 
third and fourth rows). To quantitatively compare the affinities of IF2(GTP) and IF2(ppGpp) for 
the 30S IC, we extracted kinetic and thermodynamic parameters from the smFRET data describing 
the binding of IF2 to the 30S IC. We find that IF2(ppGpp) has a significantly lower affinity for the 
30S IC compared to IF2(GTP), with an equilibrium dissociation constant (Kd) that is ~10-fold 





Figure 5.5. ppGpp inhibits IF2 function in catalyzing rapid 50S subunit joining 
The binding of IF2 to the 30S IC and the conformation of 30S IC-bound IF2 in the presence of (A) 
GTP and (B) ppGpp were directly observed by single-molecule fluorescence resonance energy 
transfer (smFRET) using an IF2-tRNA smFRET signal. First row: Cartoon representations of 30S 
ICs assembled using Cy3 FRET donor fluorophore-labeled fMet-tRNAfMet and Cy5 FRET 
acceptor fluorophore-labeled IF2(GTP) or IF2(ppGpp). Second row: Plots of Cy3 (green) and Cy5 
(red) fluorescence emission intensity versus time trajectories. Third row: Plots of the EFRET versus 
time trajectories corresponding to the plots of Cy3 and Cy5 fluorescence intensity trajectories in 
the second row. Fourth row: Surface contour plots of the post-synchronized time evolution of 
population FRET. These plots are generated by superimposing the EFRET versus time trajectories 
of individual IF2 binding events such that the start of each event is computationally post-
synchronized to time = 0 sec, thereby allowing visualization of the time evolution of population 
FRET for the entire population of IF2 binding events. “N” indicates the total number of individual 




(The experiments in Figure 5.5 were performed by Jaewook Ryu.  Data was analyzed by Jaewook 
Ryu and Kelvin Caban.)   
  
Table 1. Association rate constant (ka), dissociation rate constant (kd), and equilibrium 
dissociation constant (Kd) for the interaction of IF2(GTP) and IF2(ppGpp) with the 30S IC. 
 
 ka (µM–1 s–1)a kd (s–1)a Kd (nM)a 
IF2(GTP) 4.9 ± 0.2 0.032 ± 0.003b 6.5 ± 0.2 
IF2(ppGpp) 3.3 ± 0.3 2.0 ± 0.3 616 ± 140 
a ka, kd, and Kd were obtained from three independently 
collected datasets (mean ± SE) 
b kd was corrected for the effects of Cy5 photobleaching as 
described in Methods 
We then compared the conformations of IF2(ppGpp) and IF2(GTP) on the 30S IC by plotting 
histograms of the EFRET values observed under each condition (Figure 5.6). Consistent with our 
previous studies, we observed a single non-zero peak centered at an <EFRET> of ∼0.74 for 30S 
IC-bound IF2(GTP), corresponding to a distance between our labeling positions of ∼46.2 Å 
(assuming a Förster distance, R0, of ∼55 Å; ref. 58) (Figure 5.6 A). In contrast, we observed a 
single nonzero peak centered at a significantly lower <EFRET> of ∼0.53 (P < 0.005) for 30S IC-
bound IF2(ppGpp), corresponding to a distance between our labeling positions of ∼53.9 Å, an 
increase of ∼7.7 A relative to IF2(GTP) (Figure 5.6 B). Notably, the EFRET distribution of 30S 
IC-bound IF2(ppGpp) closely resembles that of 30S IC-bound IF2(GDP) (57). Thus, the 30S IC- 
bound IF2(ppGpp) exhibits a conformation that is similar to an IF2 inactive for rapid subunit 





Figure 5.6. IF2(GTP) and IF2(ppGpp) exhibit distinct conformations when bound to the 
30S IC  
One-dimensional histograms of EFRET value distributions corresponding to the interaction of IF2 
with the 30S IC for (A) IF2(GTP) and (B) IF2(ppGpp). Both histograms were fitted to a two-
Gaussian mixture model in which the Gaussian centered at the zero EFRET value corresponds to the 
IF2-free state of the 30S IC and the Gaussian centered at the non-zero EFRET value corresponds to 
the IF2-bound state of the 30S IC. However, for the histogram corresponding to IF2(ppGpp), the 
IF2-bound state was re-fitted to a single Gaussian for datapoints in which EFRET > 0.2 (inset). The 
center of each fitted Gaussian was used to determine the mean EFRET value for the corresponding 
state (<EFRET>). The Gaussians corresponding to the IF2-free, IF2(GTP)-bound, and IF2(ppGpp)-
bound states of the 30S IC had <EFRET>s of ~0.0 (in both histograms), ~0.74, and ~0.53, 
respectively.  
(The experiments in Figure 5.6 were performed by Jaewook Ryu.  Data was analyzed by Jaewook 





5.5 (pp)pGpp binding to IF2 mediates translation inhibition during transition phase 
My identification of an IF2 allele that is less sensitive to (pp)pGpp in vitro enabled me to test 
the initial hypothesis that (pp)pGpp accumulation reduces protein synthesis in vivo because 
(pp)pGpp binds IF2 and inhibits its function in translation. To do this, I generated a B. subtilis 
strain expressing, as the sole source of IF2, a mutant protein containing the mutations G226A and 
H230A that in vitro exhibits reduced ppGpp binding without substantially affecting IF2 function 
(Figure 5.3 C, Figure 5.4 B). This strain grows equivalently to the wildtype parent throughout all 
phases of growth, validating that the mutant IF2 is functional in vivo (Figure 5.8 A). I tested how 
these mutations affect protein synthesis during late transition phase since in the wildtype 
background, protein synthesis is strongly inhibited in a subpopulation of cells during this period 
(Figure 5.7 A). Mutations in IF2 that affect its binding to (pp)pGpp appear to significantly 
attenuate this phenotype (Figure 5.7 A, B). I quantified the effect of these mutations in IF2 by 
quantifying the number of “OFF” cells in this strain compared to wildtype across three independent 
experiments before and observe that the G226A H230A IF2 strain has significantly less cells with 
comparatively low protein synthesis compared to wildtype (Figure 5.8 B). This attenuation is 
similar to that observed in the complete absence of (pp)pGpp (Fig 3.8), consistent with it resulting 
from a direct interaction of (pp)pGpp with IF2. Thus, during transition phase, (pp)pGpp binding 





Figure 5.7 IF2 mediates inhibition of protein synthesis by (pp)pGpp during late transition 
phase. IF2 was validated as an in vivo target of (pp)pGpp by measuring protein synthesis in a 
strain expressing an IF2 G226A H230A double mutant. (A) Representative pictures of WT (JDB 
1772), (pp)pGpp0 (JDB 4294), and G226A H230A infB (JDB 4297) strains labelled with OPP 
during late transition phase. (B) Distributions of mean cell fluorescence of WT, (pp)pGpp0 and 
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Figure 5.8 Growth curve and % of population “OFF” throughout growth in WT and G226A 
H230A infB strains (A) Growth curve of G226A H230A IF2 strain is equivalent to WT. (B) % 
of population ON were quantified from ~1400 cells in three separate experiments (means ± SDs). 












































6 Summary and future directions 
6.1 Summary 
6.1.1 Signaling via a cell wall sensitive kinase is essential to downregulation of protein 
synthesis 
The work presented in this thesis identifies a mechanism that mediates the shutdown of 
protein synthesis, the most energy-intensive process in a growing cell. In Chapter 3, I observed 
that populations of B. subtilis exhibit bimodality in protein synthesis during entry into stationary 
phase, with one subpopulation that has comparatively low levels of protein synthesis and the other 
having comparatively high levels (Figure 3.3). Next, I showed that this bimodality is dependent 
on the presence of an eSTK signaling system that is sensitive to changes in cell wall synthesis 
(Figure 3.6). I connected signaling through this eSTK with a gene that had been previously 
suggested to produce a nucleotide second messenger that is involved in the shutdown of energy-
intensive processes during bacterial quiescence. I also showed that the bimodality observed was 
dependent on (pp)pGpp and that these nucleotides are necessary for the shutdown of protein 
synthesis during entry into stationary phase (Figure 3.8). Following this initial observation, I 
investigated two questions. Firstly, how is bimodality regulated during entry into stationary phase? 
Secondly, is protein synthesis down-regulated in a direct manner, and if so, how?  
6.1.2 Cross-talk between guanosine nucleotide controls heterogeneity in protein synthesis 
In Chapter 4, I first dissected the bimodality in protein synthesis by asking if any of the 
(pp)pGpp synthetases whose expression increases during exit from rapid growth (SasA and SasB) 
are responsible on their own for the heterogeneity observed. I show that although both SasA and 
SasB are necessary for bimodality, they do not all affect bimodality in the same way (Figure 4.1). 
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Whereas SasB (which primarily makes ppGpp) is important for the population with comparatively 
low level of protein synthesis, SasA (which makes pGpp) is essential for the other population 
(Figure 4.1). I showed that the cells with higher SasA expression, but not lower SasB expression, 
were more likely to have higher rates of protein synthesis, suggesting that SasA is responsible for 
the heterogeneity (Figure 4.2). I further showed that allosteric activation of SasB by the main 
product of RelA (pppGpp) is also essential for the bimodality observed (Figure 4.3). Next, I show 
that SasB allosteric activation by pppGpp is inhibited by pGpp (Figure 4.4). Finally, I provided in 
vivo evidence that the crosstalk between these two nucleotides is responsible for the bimodal 
distribution of protein synthesis (Figure 4.6). 
6.1.3 (pp)pGpp directly inhibits translation initiation during entry into stationary phase 
Having defined the network of (pp)pGpp synthetases that regulates cellular heterogeneity in 
protein synthesis, I next investigated how protein synthesis is inhibited in the cells with lower 
levels of protein synthesis. In Chapter 5, I first showed that ppGpp is sufficient to inhibit protein 
synthesis in vitro and in vivo (Figure 5.1/5.2). I further show that this inhibition is due in part via 
a direct binding of ppGpp to the translational GTPase involved in initiation (IF2) in vitro and in 
vivo (Figure 5.3). I also show that the presence of cells with low rates of protein synthesis during 
entry into stationary phase is dependent on ppGpp binding to IF2 (Figure 5.7). Lastly, in 
collaboration with Ruben Gonzalez’s lab, we showed that ppGpp fails to allosterically activate IF2 
in a conformation that allows it rapidly mediate translation initiation (Figure 5.5).   
The work presented here, therefore, defines a mechanism by which bacteria heterogeneously 
regulate protein synthesis during entry into quiescence. The bimodal distribution in protein 
synthesis is controlled by crosstalk between two nucleotides on SasB (Figure 6.1). In response to 
amino acid limitation, RelA synthesizes pppGpp, which allosterically activates SasB (Figure 6.1 
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A). In response to changes in cell wall metabolism, PrkC regulates noisy expression of sasA 
(Figure 6.1 A). The crosstalk of the two molecules that RelA and SasA generate (pppGpp and 
pGpp respectively) converge on SasB, and pGpp inhibits the allosteric activation of SasB (Figure 
6.1 A). The activation of SasB in approximately half the population during late transition phase 
leads to an accumulation of ppGpp (Figure 6.1 B). In these cells, ppGpp mediates the 
downregulation of protein synthesis by directly regulating translation initiation. ppGpp achieves 
this downregulation by directly binding to the essential GTPase IF2. A ppGpp bound IF2 is not 
allosterically activated compared to a GTP bound IF2 molecule, and a ppGpp bound IF2 is not 




Figure 6.1 Model for heterogenous down-regulation of protein synthesis during entry into 
quiescence. In response to amino acid limitation, RelA synthesizes pppGpp. In response to 
changes in cell wall synthesis, PrkC regulates noisy expression of sasA. Whereas pppGpp 
allosterically activates SasB, pGpp (the product of SasA) inhibits this activation. The crosstalk of 
these two nucleotides, therefore, determines how much ppGpp SasB produces. Lastly, ppGpp 
accumulation directly inhibits translation initiation by binding to IF2. (B) In cells with relatively 
higher sasA (‘A’) expression, increased inhibition of SasB (‘B’) allosteric activation by RelA (‘R’) 
results in relatively high protein synthesis. In cells with relatively lower sasA expression, decreased 
inhibition of SasB allosteric activation attenuates protein synthesis to a greater extent than in cells 
with lower sasA expression. 
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6.2 Future directions 
6.2.1 What signal(s) mediate down regulation of protein synthesis? 
In Chapter 3, I showed that protein synthesis decreases as cells exit from rapid growth 
(Figure 3.3). I also showed that this down-regulation of protein synthesis depends on signaling 
through an eSTK signaling system (PrkC/PrpC) (Figure 3.6). The subject of this thesis has been 
to define the mechanisms that act downstream of PrkC/PrpC signaling. Previous observations 
show that PrkC/PrpC signaling controls expression of a gene that had previously been shown to 
have (pp)pGpp synthetase activity (sasA) (64). Furthermore, expression of the two small alarmone 
synthetases (sasA and sasB) increases during exit from rapid growth in B. subtilis. Using this 
information, I postulated that (pp)pGpp could mediate the shut-down protein synthesis. I then 
demonstrated that (pp)pGpp is necessary for the shut-down of protein synthesis (Figure 3.8). 
These initial observations suggest that when cells exit rapid growth, they sense a change in cell 
wall homeostasis using PrkC. This signal is then communicated to other cellular processes through 
the accumulation of (pp)pGpp; at this point, however, the exact signals that are sensed have not 
been experimentally determined. However, PrkC is known to be essential for the resuscitation of 
B. subtilis spores in response to muropeptides released from actively growing cells (60). 
Furthermore, the PASTA domain of PrkC has been experimentally shown to bind these 
muropeptides (135). This suggests that part of the signal that cells are sensing during entry into 
stationary phase heterogeneity is the presence or absence of cell wall homeostasis.    
In Chapter 5, I showed that the product of SasB (ppGpp) inhibits IF2 function and inhibits 
translation (Figure 5.3/5.7). In Chapter 4, I showed that the products of RelA and SasA (pppGpp 
and pGpp) regulate the activity of SasB (Figure 4.4). This suggests that the signals that cells sense 
when they are exiting rapid growth are integrated through RelA and SasA. RelA is known to sense 
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the amino acyl status of tRNAs as a proxy for availability of amino acids (74). It seems, therefore, 
that part of the signal that cells integrate into the decision to shut off protein synthesis is amino 
acid availability. The observations that SasB allosteric activation is modulated by the nucleotide 
generated by SasA (Figure 4.4) suggest that the signal that stimulates SasA activity is also 
important. SasA expression is stimulated during cell wall stress (83). It, therefore, seems that both 
amino acid availability and cell wall homeostasis are important signals for cells to regulate protein 
synthesis and potentially other energy-intensive purposes.   
How important are either of these signals? I have not made exact measurements of how 
amino acid availability changes under the conditions I used. I have, however, provided evidence 
that cell wall synthesis decreases during exit from growth and entry into stationary phase 
(Appendix D, Figure 1). The probe that I utilized to show this, however, has a low dynamic range 
during the transition from growth to stationary phase (Appendix A, Figure 2, 3). Due to this, I am 
not able to correlate rates of cell wall synthesis with rates of protein synthesis on a single cell level 
during the late transition phase. Such a measurement would provide evidence that individual cells 
coordinate cell wall synthesis and protein translation.    
6.2.2 Does SasB have another physiological stimulus? 
The previous observation that SasB is allosterically (85) activated and the data which I 
have shown in Chapter 4 of this thesis indicates that SasB is only in part transcriptionally activated. 
This suggests that the activity of SasB is stimulated by the signal that activates its transcription 
along with any other signal that affects its allosteric activation. Expression of the sasA and sasB 
homologs (relP and relQ) in E. faecalis is stimulated in response to treatment with cell wall active 
antibiotics (84). Furthermore, deletion of both relP and relQ causes decreases in viability during 
treatment with the cell wall active antibiotic vancomycin (84). These data together suggest that the 
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transcription of sasB is stimulated in response to changes in cell wall synthesis. This has not been 
experimentally determined as it has for sasA (64, 83). Future experiments would examine this 
possibility 
The allosteric activation of SasB is known to be mediated by the major product of RelA 
(pppGpp) (85). Here I have shown that this is modulated by the product of SasA (pGpp) (Figure 
4.4). SasB allosteric activation has also been shown to be inhibited by ssRNA (86). Specifically, 
ssRNAs with a sequence with close identity to the consensus Shine-Delgarno sequence (GGAGG) 
competitively compete with pppGpp (86). This has led to the suggestion that SasB could be a 
sensor for mRNA (136). This raises the possibility that SasB could serve to sense the presence of 
mRNA and would integrate this information into the cellular response. For example, SasB activity, 
which I have shown inhibits protein synthesis (Figure 5.2), would be fine-tuned based on the amino 
acid availability (through pppGpp made by RelA), cell wall synthesis (by direct competition of 
pGpp made by SasA and pppGpp), and presence or absence of mRNA (by direct competition of 
mRNA with pppGpp).   
6.2.3 What are the structural aspects that mediate differential guanosine synthesis? 
Sequence homology between the SasB and SasA proteins is high (39.11% identity) (137). 
Furthermore, sequence homology between the synthetase domain of RelA and SasB and SasA is 
high (29.52% and 33.02% identify, respectively) (85). How do these closely related domains 
generate different nucleotides? In B. subtilis, stimulation of RelA activity during log growth 
primarily produces pppGpp (82). In contrast, expression of SasB under similar conditions 
primarily produces ppGpp, and expression of SasA produces pGpp (79). This difference is 
presumably due to a difference in preferential use of a particular substrate. Specifically, RelA 
presumably preferentially utilizes GTP and ATP to make pppGpp, whereas SasB utilizes GDP and 
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ATP to make ppGpp, and SasA utilizes GMP and ATP to make pGpp. Differences in guanosine 
substrate, therefore, seem to underlie the difference in alarmone production. How is this difference 
mediated? One possibility is that each enzyme binds a particular nucleotide with greater affinity. 
Alternatively, catalysis rates by each enzyme could be different depending on guanosine substrate. 
Biochemical experiments of binding affinity and enzymatic rates using the different nucleotides 
could answer this question. These nucleotides are structurally similar; they differ from each other 
only in 1 to 2 phosphate groups on the 3’ carbon. What structural aspects of these closely related 
proteins mediate this? An NMR spectroscopy study looking at how residues shift when each of 
these proteins is bound to different guanosine substrates could provide candidate residues that 
mediate this difference. This kind of study previously showed differences in binding of GDP and 
ppGpp to IF2 (75). I used these differences to identify candidate residues that could affect binding 
of ppGpp specifically and generated an IF2 protein that bound ppGpp with a lowered affinity(99). 
Ultimately, engineering a mutant synthetase domain that reverses the substrate specificity of a 
particular synthetase would definitively demonstrate which residues are important for this 
phenomenon.    
6.2.4 Do other nucleotides (pppGpp and pGpp) affect IF2 function like ppGpp 
In Chapter 5, we showed using biochemical and biophysical methods that IF2 function is 
inhibited by ppGpp (Figure 5.2/5.8). What about the other closely related nucleotides? Chapter 4 
of this thesis shows data that suggest that these three nucleotides do not all have the same function. 
Furthermore, recent work shows that while ppGpp effectively inhibits IF2’s ability to form 30S 
initiation complexes (30S ICs), the closely related pppGpp actually allows IF2 to form 30S ICs 
(although at a lower efficiency than GTP (138). A biochemical analysis of IF2 function using the 
in vitro translation reaction used in Chapter 5 in the presence of either pppGpp and pGpp would 
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answer if IF2 is inhibited by pppGpp and pGpp to the same extent as it is with ppGpp. The 
structural aspects of the effect of pppGpp and pGpp on IF2 could be elucidated using the single-
molecule method developed by Ruben Gonzalez’s lab and used in Chapter 4 of this thesis. These 
experiments require that enough nucleotide is used to fully saturate IF2 with the specific nucleotide 
in question, and so a binding study to show the affinities of IF2 for pppGpp and pGpp is also 
required. The single-molecule studies using IF2 and pppGpp have already been initiated in the 
Gonzalez lab, and preliminary data suggest that pppGpp positions IF2 in a confirmation more 
similar to GTP than ppGpp. However, these experiments require further validation.  
6.2.5 Role of EF-Tu in inhibiting protein synthesis during accumulation of ppGpp 
Chapter 5 of this thesis identified IF2 as a target of ppGpp on the translation machinery. It 
also shows that IF2 binding to ppGpp is necessary for the population of cells with low levels of 
protein synthesis during entry into stationary phase (Figure 5.6). I showed this by generating an 
IF2 molecule that has a lower affinity for ppGpp than WT IF2 (Figure 5.3). The residues which 
are mutated in this IF2 protein are in the G1 domain of the guanosine binding site of IF2 and make 
the mutant protein have a G1 domain that resembles the G1 domain of EF-G (Figure 5.3). This 
mutation strategy was designed given the lower binding affinity (approximately 10X lower Kd) of 
EF-G to ppGpp (125). The other GTPase involved in elongation (EF-Tu) has previously been 
suggested to also mediate the inhibition of protein synthesis because its binding affinity to ppGpp 
is similar to IF2 (125). Interestingly, EF-Tu also resembles IF2 in regard to the residues that we 
identified as being important for binding of ppGpp. During the course of investigating the potential 
targets for ppGpp, I attempted to generate a mutant EF-Tu protein that carried the homologous 
mutations that I used to show that IF2 is a target of ppGpp. Unfortunately, I was unable to either 
express this mutant protein in E. coli, or to generate B. subtilis strain that carried the mutation in 
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EF-Tu. I believe that the reason for this has to do with the fact that the changes that affect ppGpp 
binding also affect GTP binding. I showed that this is true for IF2 but that the difference did not 
significantly affect IF2 function in the in vitro translation reaction, and it apparently does not affect 
in vivo function because the strain carrying these mutations does not have any noticeable growth 
defect. Unlike IF2, the defect in EF-Tu appears to be more severe and therefore precludes any 
analysis like the ones performed on IF2. It is possible that additional analysis of the residues which 
mediate binding of ppGpp specifically to EF-Tu would potentially allow for a more directed 
mutation strategy that would allow for the generation of an EF-Tu mutant with similar properties 
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Table 2. Strains used in this thesis 
168 trpC2 (WT) Lab stock JDB 1772 
trpC2 DsasA::kan (139) JDB 4310 
trpC2 DsasB::tet (139) JDB 4311 
sacA::PsasB-YFP (cm) unpublished JDB 4341 
sacA::PsasA-YFP (cm) (64) JDB 4030 
trpC2 sasBF42A unpublished JDB 4340 
trpC2 relAY308A unpublished JDB 4300 
trpC2 DsasA::kan DsasB::tet (139) JDB 4312 
trpC2 DsasA::kan relAY308A unpublished JDB 4301 
168 trpC2 DprpC (140) JDB 1773 
168 trpC2 DprkC (140) JDB 1774 
trpC2 DywaC::kan 
DyjbM::tet DrelA::erm 
(141) JDB 4294 
trpC2 amyE:Pxyl-yjbM spc 
DywaC::kan DyjbM::tet 
DrelA::erm 
unpublished JDB 4295 
trpC2 subtilis infBG226A H230A (99) JDB 4297 
MG1655 Lab stock JDE 1497 
BL21 pETPHOS B. subtilis 
infB 
(99) JDE 3077 
BL21 pETPHOS B. subtilis 
infBG226A H230A 
(99) JDE 3078 
BL21 pETPHOS B. subtilis 
fusA 
(99) JDE 3075 
BL21 pETPHOS E. coli 1-
455 relA 
(99) JDE 3079 
DH5a pMINIMAD2 B. 
subtilis relAY308A 
unpublished JDE 3115 
DH5a pMINIMAD2 B. 
subtilis sasBF42A 
unpublished JDE 3135 
DH5a AEC 127 B. subtilis 
PsasB 
unpublished  
BL21 pETPHOS B. subtilis 
sasB 
unpublished JDE 3136 
BL21 pETPHOS B. subtilis 
sasBF42A 
unpublished JDE 3137 
BL21 pETPHOS B. subtilis 
yvcI 




Table 3. Oligos used in this thesis 
GGCTAGAATTCTGATGCTCTTCCTTTCCG This study  yjbM operon 
promoter EcoRI F 
GGCTAGGATCCACAAAGTACAGATTCATTT
T 
This study yjbM operon 
promoter BamHI R 
GGGCCCGAATTCGATGACAAACAATGGGA
G 
This study F42A yjbM EcoRI F 
pMINIMAD2 
GGGCCCGTCGACTTGTTGCTCGCTTCCT This study F42A yjbM SalI R 
pMINIMAD2 
TTCACCGATCGAAGCTGTGACCGGACGCG This study yjbM F42A F 
CGCGTCCGGTCACAGCTTCGATCGGTGAA This study yjbM F42A R 
CATCTTTCGTTTTTTTCTTG This study Y308A relA EcoRI F 
pMINIMAD2 
TGGGCTTCATTCGTTTTG This study Y308A relA BamHI 
R pMINIMAD2 
AGCCGAATATGGCTCAATCGCTTCA This study Y308A relA F 
TGAAGCGATTGAGCCATATTCGGCT This study Y308A relA R 
CCGGGCATATGGATGACAAACAATGG This study yjbM NdeI F 
GGGAAAACTAGTCTATTGTTGCTCGCTTCC This study yjbM SpeI R 
GGGCCCCATATGGTGACGTACTTGCAAAG
A 
This study yvcI NdeI F 
GGGCCCACTAGTCTATTTGATGTGCTGCGG This study yvcI SpeI R 
GGGAAAGAATTCATGGCTAAAATGAGAGT
ATACG 
This study infB EcoRI F 
GGGAAAGGATCCATTCAAACCGGTAATTT
CAACC 
This study infB BamHI R 
GACAATCATGGCTCACGTTGACC This study infB G226A F 
GGTCAACGTGAGCCATGATTGTC This study infB G226A R 
CCACGTTGACGCTGGGAAAACAA This study infB H230A F 
TTGTTTTCCCAGCGTCAACGTGG This study infB H230A R 
GGGAAACATATGGCTAAAATGAGAGTATA
CG 
This study infB NdeI F 
GGGAAAGGATCCGCAAATCCGATCACGTT
CTTTCAATTTCTTGC 
This study infB BamHI R 
GGAAGTCGACAAGGAGGGCGAAAAATGG
ATTTATCTGTAACACATA 
This study fusA NdeI F 
CCCAAAGGATCCTTAATCCACTTCTTTCTT
AATC 
This study fusA BamHI R 
GATCGGATCCGCGGCCGCTTCTAGAGGGA
GTTCTGAGAATTGGTATGC 
This study E. coli relA NdeI F 
GATCAAGCTTAACTACATTTATTGTACAAC
ACGAGC 
This study E. coli relA N-





Table 4. Plasmids used in this thesis 
pETPHOS  Lab stock 
pMINIMAD2 (142) 
AEC 127 (64) 
pETPHOS WT sasB unpublished 
pETPHOS sasBF42A unpublished 
pETPHOS yvcI unpublished 
pMINIMAD2 relAY308A unpublished 
pMINIMAD2 sasBF42A unpublished 
AEC 127 PsasB unpublished 
pDR150 Lab stock 
pSac-cm Lab stock 
pDR150 yjbM unpublished 
pMINIMAD2 G226A H230A B. subtilis infB (99) 
pETPHOS B. subtilis infB (99) 
pETPHOS G226A H230A B. subtilis infB (99) 
pETPHOS B. subtilis fusA (99) 





Cell wall synthesis decreases during exit from rapid growth.   
 The data provided in this thesis sets up a model for the down-regulation of protein synthesis 
in a heterogenous manner during entry into stationary phase (Figure 6.1). Specifically, this model 
describes how during entry into stationary phase, one subpopulation of cells downregulates protein 
synthesis to a greater extent than the rest of the population. This thesis dissects the molecular 
mechanism by which heterogeneity is regulated in chapter 4 and the mechanism that directly 
downregulates protein synthesis in the cells with comparatively low levels of protein synthesis in 
chapter 5. Importantly, the mechanism that regulates heterogeneity in protein synthesis is 
dependent on the activity of both RelA (whose activity is stimulated by amino acid availability) 
and SasA (whose expression is regulated by the cell wall sensitive kinase, PrkC). The regulation 
of sasA expression is particularly interesting because it is subject to extrinsic noise that is 
dependent on PrkC (64). In chapter 4, I also showed that cells with higher sasA expression are 
more likely to have higher protein synthesis, suggesting that noise in sasA expression could be 
directly responsible for the heterogeneity I observed. The extracellular PASTA domain of PrkC is 
known to directly bind peptidoglycan fragments (61), and PrkC is essential for muropeptide 
mediated spore germination (60), indicating that PrkC directly senses changes in cell wall 
synthesis. Because of this, I wished to directly ask if changes in cell wall synthesis could be 
mediating the difference between cells with comparatively low and high levels of protein 
synthesis.   
To do this, I first observed how cell wall synthesis changed throughout growth by using 
the fluorescent D-amino acid (FDAA) 7-hydroxycoumarincarbonylamino-D-alanine (HADA) that 
covalently labels newly synthesized peptidoglycan (143). HADA is a structural analog of the D-
115 
 
alanine residues that are part of the peptides that cross-link glycan strands in peptidoglycan (143). 
Incorporation of HADA occurs efficiently during exponential phase and is most visible at the 
division septum in B. subtilis as previously observed (143) (Appendix D Figure 1). During exit 
from rapid growth (early transition phase) HADA incorporation decreases dramatically, and 
during late transition phase, most cells have HADA incorporation that is no higher than the 
background (visible in the single red line at 200-210 a.u bin) (Appendix D Figure 1). Given that 
the range in HADA incorporation is low even during early transition phase (99% of the population 
is between 200 and 250 a.u.) compared to OPP incorporation (99% of the population is between 
1000 and 2000 a.u.), it is unlikely that a meaningful correlation can be derived between these two 
probes (Appendix Figure 2 A). Indeed the correlation between both of these probes is low (R2 
0.2263) (Appendix Figure 2 C left). 
 
Appendix D Figure 1. Cell wall synthesis decreases during entry into stationary phase. Top 
row. Microscopy images of HADA incorporation depicted in green and phase contrast in red. 





















































































































 I wanted to explore the possibility that under certain conditions, I could increase HADA 
signal in order to correlate it with OPP in single cells. Peptidoglycan is a mesh-like polymer made 
up of glycan strains that are cross-linked to each other by short peptides (144). These peptides 
extend from the glycan strand typically in this order; an L-alanine, a D-glutamic acid, a dibasic 
amino acid (typically a meso-diaminopimelic acid (mDAP) or an L-lysine), a D-alanine, and 
another D-alanine. In B. subtilis, this pentapeptide is cleaved between the two D-alanine residues 
by the carboxypeptidase PBP 5 (encoded by the gene dacA). I reasoned that if I could somehow 
inhibit this enzyme, it would increase the signal from HADA because the last HADA molecule 
incorporated would not be cleaved. Recently, the penicillin like drug 6-aminopenicillanic acid (6-
APA) was shown to selectively inhibit PBP 5 (145). Consistently, addition of 6-APA to cells 
during early transition phase increased HADA incorporation without any apparent effect on OPP 
incorporation (Appendix Figure 2 A, B). Although HADA incorporation increases in the presence 
of 6-APA, the range of signal is still low compared to OPP 99% of the population is between 250 
and 330 a.u) next asked if addition of 6-APA affected the correlation observed between HADA 
and OPP incorporation. I did not observe any difference in R2 when OPP and HADA are correlated 
between cells treated with or without 6-APA (Appendix Figure 2 C). Consistently, a DdacA 
mutant also does not have increased correlation between OPP and HADA incorporation 
(Appendix Figure 3).  
 At this point, I am not able to correlate OPP incorporation with HADA. However, I cannot 
definitively say that this lack of correlation is not due to the low signal provided by HADA 






Appendix D Figure 2. Cell wall synthesis in the presence of 6-APA during early transition 
phase. Population distributions of OPP (left) and HADA (right) incorporation in the absence (A) 
of 6-APA and presence of 10X the MIC of 6-APA (B). (C) Plots depicting correlation of single 
cells labeled with OPP (Y-axis) and HADA (X-axis) during early transition phase in the absence 
































































































Appendix D Figure 3. Correlation between OPP and HADA incorporation in a DdacA 
mutant. Plot depicting correlation of single cells labeled with OPP (Y-axis) and HADA (X-axis) 
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